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ABSTRACT
Chitosan is examined as a non-viral vector capable of efficient gene delivery due
to its favorable properties such as biodegradability, biocompatibility, and is non-toxic to
mammalian cells. Cell modifications and vector permeability are enhanced in non-viral
vectors that incorporate electrostatic interactions. This work synthesizes cationic (N +, P+)
chitosan derivatives, to enhance electrostatic interactions towards nucleotides, using
amide coupling agents EDC and HOBt. The final chitosan derivatives will bear cationic
functional groups (N +, P+) with various alkyl groups (Me, Et, Pr, Ph) to examine their
affinities to nucleotides and antifungal properties. mPEG grafted cationic chitosan
derivatives were also synthesized to examine enhanced cell permeability. 1 H NMR and
FT-IR analysis are implemented to observe coupling of cationic ligands to chitosan and
examine electron withdrawing effects of changing cationic groups. Turbidity studies were
conducted to test chitosan derivatives for pH-dependent solubility. Changes in chitosans
stability through loss of intramolecular interactions after ligand coupling was analyzed
using TGA-DTG. CD and agarose gel electrophoreses were used to observe cationic
chitosan derivatives affinity to nucleotides. Fluorescence Microscopy and Yeast Growth
Assays examined anti-fungal properties of cationic derivatives. This work aims to
investigate ammonium and phosphonium chitosan derivatives as a viable gene therapy
candidate capable of enhanced affinity toward nucleotides.
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CHAPTER 1. INTRODUCTION

1.1. Chitin and Chitosan
Chitin is the most abundant nitrogen-bearing organic compound and second most
abundant polysaccharide found in nature.1,2 Its polymer chain is comprised of linear β(1,4)-linked N-acetyl glucosamine units, as seen in Figure1.3,4 The most common sources
of chitin are crustaceans, shrimp, and crab shells, through demineralization and
deproteinization.1,5 By the late 1950’s, professor C. Rought discovered chitosan by
boiling chitin in concentrated alkaline solution, removing the N-acetyl groups (Figure 1),
a process known as deacetylation.6,7 The deacetylation of chitin decreases this hydrogen
bonding affect which decreases the molecular stability of the polymer chain compared to
other polysaccharides such as cellulose. 8,9 Chitin and chitosan are very similar polymers
with various degrees of N-acetylated glucosamine units. The primary distinction between
chitin and chitosan is the percent of acetyl groups remaining along the polymer chain.
These two polymers, chitin, and chitosan, are a polymer blend where both Ndeacetylated, and N-acetyl glucosamine units are arranged throughout the length of the
polymer.9 Unlike chitosan, chitin exhibits intramolecular hydrogen bonding through its
acetyl and hydroxyl groups giving it a three-dimensional α-helices structure.3,10 When
more than 50% of N-glucosamine units have an acetyl group present, then the polymer is
chitin. When 50% or more of acetyl groups have been removed, the polymer is named
chitosan. The degree of acetylation (DA) is the determining factor that distinguishes their
names and properties.

Figure 1. Displays chitin being deacetylated by a deacetylase into chitosan.
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Although chitosan’s structure is similar to that of other polysaccharides such as
cellulose, it does not share many of its properties. Chitosan is insoluble in both organic
and neutral to basic aqueous solvents. It was discovered that chitin with a DA less than
sixty percent is soluble in dilute, acid solutions. 1 At pH 6, the free amino groups found on
chitosan’s N-deacetylated units begin to protonate, which slowly increases solubility. The
increased solubility at lower pH’s allows for synthetic modifications to take place in
solution. The protonation of free amino groups at lower pH’s allows for the formation of
ionic cross-linking with multivalent ions.1 Like cellulose, chitosan has secondary and
primary hydroxyl groups, which, once in solution, can be synthetically modified. The
ability to synthetically alter chitosan’s amino and hydroxyl groups gives rise to a variety
of applications ranging from soaps, cosmetics, water treatment, protein separation, gene
delivery, and cancer treatments.1,4,11-20
The applications of chitosan can be dictated by two main factors, DA and its
molecular weight (MW). The DA and MW allow for specific physicochemical
interactions making chitosan a suitable non-viral vector.1 DA can determine many of
chitosan’s physical and chemical characteristics. The lower percentage of DA, the more
available amino groups are present for modifications and protonation.
The stability of chitin’s α-helix structure is disrupted by a lower percentage of DA
and an increase in protonation of free amino groups. The disruption of intramolecular
interactions allows for greater solvation and cationic interactions. When DA is greater
than sixty percent, intramolecular hydrogen bonding and hydrophobic methyl groups
make chitin insoluble in water.1,5,21 As DA decreases, the solubility of chitin increases
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with decreasing pH. With lower DA, chitin is less sterically hindered and has less
intramolecular interactions.5,21,22
The microbial degradation of chitosan is correlated to two main factors: the DA
and distribution of N-acetylated glucosamine units throughout the polymer chain. Lee et
al.13 observed that chitosan’s degradation process rapidly declines after DA reaches lower
than 30%. Similarly, the work of Aiba et al. 12 concluded that chitosan with homogenous
distribution of N-acetylated glucosamine units was less susceptible to degradation within
lysosomal space.13 Controlling DA and distribution of N-acetylated glucosamine units
affects chitosan’s ability to degrade within biological systems. 13
Like DA, MW significantly affects chitosan’s function in a variety of applications
including burn healing, coagulation of pollutants, lowering blood cholesterol levels,
enhancing drug dissolution, control of viscosity and improving crop yields. 1,23 The MW
has been reported to influence the growth of E. coli. Higher MW prevented E. coli.
growth, while lower MW promoted it.24 Sodium nitrite (NaNO2 ) can be used to
depolymerize chitosan controllably, allowing for a wide variety of different MW
chitosan.24
The MW of chitosan can determine the strength of interaction between DNA and
chitosan. When electrostatic attraction occurs between protonated chitosan and DNA in
acidic solution, higher MW chitosan can wrap around short double-stranded DNA and
create a stronger interaction through entanglement. 25 Low MW chitosan has been proven
to be less effective at condensing short double-stranded DNA due to lack of this
entanglement effect.1,26 These electrostatic interactions between DNA and chitosan are
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generated by the protonation of chitosan’s free amino groups. However, this interaction is
reversed at increasing the pH.
Chitosan may be chemically modified to bear pH-independent cationic groups
that can provide sustained interactions with short double-stranded DNA through a broad
pH range.24 Controlling the positive to negative charge ratio (+/-) determines the degree
of complexation of short double-stranded DNA when utilizing modified chitosan (of any
MW). Modifying chitosan to contain cationic functional groups that are not dependent on
pH can provide a means for chitosan to become a viable non-viral vector suitable for
gene therapy.

1.2. Chitosan Modification
Modifications to chitosan to improve solubility in neutral conditions were
previously investigated.1 Chitosan derivatives that bear various functional groups were
prepared for a wide variety of applications which can be seen in Figure 2.1,27-33 Chitosan’s
amino and primary hydroxyl groups allow chemical modification that can lead to an
increase in solubility and affinity to nucleotides. Although chitosan is non-toxic to
mammalian cells on its own, the addition of cationic functional groups to its polymer
chain can increase toxicity.34 Chitosan derivatives incorporating cationic triphenyl groups
into their structure have been shown to be toxic to mammalian cells. 35
The coupling of carboxylic acids to amino groups to form a more stabilized amide
was subjected to rigorous research, and many new methods have been developed in
recent years.36 The coupling of carboxylic acids to amino groups requires a preliminary
activation step to create a stable intermediate that is more reactive toward amino groups.

5

Figure 2. Various chemical modifications of chitosan and their applications.
Modifications have been made to the amino and primary hydroxyl groups.
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In 1995, Nakajima et al.37 conducted experiments where altered carbodiimides were used
to observe the effects on coupling efficiency. N,N'-dicyclohexylcarbodiimide (DCC) and
1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) were reacted with various
nucleophiles to observe the reaction mechanism. In both cases (EDC and DCC), the ratelimiting step was the formation of O-acylisourea, where the fully-protonated
carbodiimide and the carboxylate ligand react to form a reactive intermediate. The O acylisourea complex is very reactive and short-lived in solution.36 At a pH lower than six,
the intermediate hydrolizes reforming the carboxylic acid ligand and a deactivated EDCurea. At pH's between 6-8, the intermediate remains in solution long enough to encounter
amino groups and undergo successful coupling. Although coupling with EDC and DCC
has proven successful, many new additives have been studied to improve coupling
efficiency. Hydroxybenzotriazole (HOBt) has been used in carbodiimide reaction
schemes to stabilize the O-acylisourea intermediate, as seen in Figure 3. HOBt attacks the
activated EDC-carboxy intermediate and forms a more stable intermediate that can
remain in solution for an extended period of time, increasing the overall efficiency of the
EDC/HOBt coupling scheme.36 The linking of functionalized carboxylic acids to
chitosan’s primary amines has been investigated using EDC and HOBt.31,34 Using watersoluble EDC, these modifications to chitosan can take place at room temperature under
open air conditions. Using EDC followed by NHS or HOBt allows for cationic
modification to chitosan making it more efficient for short double-stranded DNA
interactions.37,

38
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Figure 3. Reaction mechanism of EDC and HOBt coupling carboxylic acid ligand to
chitosan.

1.3. PEGylation
PEGylation can be referred to as the coupling of polyethylene glycol (PEG) to
other materials such as proteins or therapeutic vectors. Chitosan’s ability to interact with
DNA has been improved through several modifications including PEGylation.38 Coupling
of PEG to chitosan produces conjugates with reduced toxicity, and increased stability in
aqueous media.39 The incorporation of PEG into many pharmaceutical applications,
including gene therapy, is not surprising and is often encouraged. 40
PEG-grafted chitosan has been prepared to lower toxicity of certain cationic
chitosan derivatives and increase water solubility. 39 Jiang et al.34 synthesized PEG-grafted
8

chitosan using methoxy PEG-nitro phenol carbonate and chitosan. 40 PEG-grafted nonviral vectors have been shown to stabilize complexation of short double-stranded DNA
through shielding of the positive charges present on modified vectors. These vectors
displayed higher solubility and complexation with short double-stranded DNA compared
to non-PEG-grafted vectors.40
PEG is one of the few hydrophilic polymers approved by the Food Drug
Association (FDA) and has proven to play a vital role in biomedical and biotechnical
fields. PEG has been used in a variety of applications ranging from cosmetics to polymerbased drug delivery systems.39 PEGs are classified as linear or branched polyether
compounds that are often found in a variety of molecular weights ranging from 3 to
40,000 g/mol.39 Low molecular weight PEGs have lower melting points and are liquids at
room temperature, while higher molecular weight PEGs have high melting points and are
crystalline at room temperature. The most commonly used PEG is methoxy polyethylene
glycol (mPEG), where one hydroxyl group has been converted into a methoxy group.39
PEGs have been shown to be soluble in many organic solvents including, but not limited
to, benzene, acetone, acetonitrile, methanol, and methylene chloride. 39 The addition of
PEG to medication and gene delivery vectors increases solubility which, in turn,
increases their overall efficiency.

1.4. Gene Therapy
Chitin and chitosan were investigated for their applications in gene therapy since
the early 1990’s when their structures were identified through infrared spectroscopy (IR).
Chitin and chitosan are among the non-viral vectors heavily researched for gene delivery
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due to their low toxicity in mammalian cells and naturally high abundance.1 Therapeutic
fields have extensively researched gene therapy for over twenty years. 1,31 Restored
function to diseased genes by the addition of new genetic material has been previously
reported.1,29 These methods have also been used as a research tool to investigate inherited
single gene disorders.29 Gene delivery vectors, or vehicles, are needed to transfer new
genetic materials into or near the desired therapeutic sites. The transfer of new genetic
material can occur through techniques such as ex vivo, in vivo, or in situ.1
Gene therapy’s main approaches utilize viral and non-viral vectors.3 Viral gene
delivery utilizes viruses to infect cells with the modified genetic material. Viruses can be
modified to stop their reproductive cycle by removing genetic sequencing needed for
reproduction. However, they still require sequences for binding and gene delivery to be
useful.33 Commonly used viral vectors include retrovirus1,41,42 adenovirus,1,4 adenoassociated viruses,43 herpes virus44 and vaccinia virus1,45 . Each viral vector listed above
has been incorporated into its own unique application. A few of these viruses listed above
can produce sustained gene expression, but only in cells that divide. Others are just as
effective against non-dividing cells without integrating into their host cell chromosome.35
Mutations in the cell can occur through the integration of viral DNA into the genomes of
the cell while using viral gene delivery systems, which can lead to safety concerns.33
The safety concerns of viral gene delivery began to grow after the accidental
death of a patient using gene therapy for immune deficiency.34 The fear of using viral
vectors resulted in increased interest in non-viral vectors. Non-viral vectors can deliver
large fragments of genetic material to mammalian cells comparable to that of viral

10

vectors.34 Non-viral vectors have proven successful, but are far less effective than viral
vectors in transfecting mammalian cells. 46
Many approaches have been investigated for improving non-viral vectors for gene
therapy. Amongst cationic polymers investigated, dendrimers and short chain, oligomers
have been found to meet the pharmaceutical standard for human use. 47,48 Dendrimers
have shown to form complexes with pDNA (polyplexes), and are regarded as one of the
most effective non-viral vectors.49 Although dendrimers seem to have been the research
standard for DNA interaction, there have been recent studies that have raised concern
over their toxicity within biological systems.50,51 Decreasing the molecular weight and
lowering the degree of branching of these dendrimers have been shown to only slightly
lower the toxicity in biological systems. 52-54 Cationic polymers that can be formed in
long-chain fashion or polycationic-spherical balls have shown to have increased
interaction with pDNA.52-55 Short-chain polymers, such as chitosan oligomers 14 units or
shorter, have been shown to have weaker interactio ns and lower overall stability.50,51
Chitosan and its family of linear polysaccharides have been proposed as biocompatible
gene delivery vectors that can be tailored for electrostatic interactions. Studies have
shown that chitosan exhibits low cytotoxicity within mammalian cells and displays
viability in gene therapy.52-56 In the research so far conducted on chitosan’s interaction
with DNA with cationic derivatives, high molecular weight chitosan has been shown to
exhibit the highest complexation and stability and delays the release of pDNA.57-61
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1.5. Anti-Yeast and Anti-Microbial
There has been increasing concern regarding resistance of microbial pathogens to
drug treatments. Although drug-resistant microbial pathogens have mostly been
controlled for the latter half of the 20th century, they can cause infections or diseases in
animals, plants, or humans.62 Microbial pathogens that have increased resistance to drug
treatments can ultimately threaten human health and social development. 62 Bacteria,
viruses, and fungi have contributed to more than one-fourth of global deaths annually,
due to outbreaks of infectious diseases. 63-65 Microbial pathogens have many ways to
spread, and controlling them is increasingly difficult. The widespread overuse of
antibiotics and disinfectants has led to development of new strains of antimicrobialresistant microbial pathogens.66-68 There has been an urgent demand for researching new
techniques of increasing the effectiveness of anti-yeast and anti-microbial agents on
microbial pathogens.
Antimicrobials have mainly consisted of natural or low molecular weight
compounds that are susceptible to resistance, which can often lead to toxicity in the
human body due to biological diffusion. 69,70 Polymeric antimicrobials have been used for
their compatibility within biological systems and lower susceptibility to resistance. These
polymers are self-stabilizing and can be used for long-term while remaining viable
antimicrobials.66-68 Polymer materials used for antimicrobials characteristically inherently
have long lasting durability and are environmentally friendly.65-70 The moieties that were
extensively researched are those bearing quaternary ammonium salts and quaternary
phosphonium salts. The cationic species have been shown to create complexations with
cell membranes and DNA to inhibit cell growth.71 These cationic groups have been
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investigated previously as disinfectant products and have displayed that ammonium salt
were more effective and used more often than their phosphonium analogs. 68 One research
group is conducting polymeric anti-yeast studies modified chitosan polymers to bear
three different cationic functional groups. 71 Ammonium and phosphonium groups were
the only two of the three groups that displayed antimicrobial properties. The
antimicrobial activities of these cationic species of chitosan were evaluated through the
cut plug method of treating bacteria and fungi.71 Phosphonium cationic derivatives
displayed a higher activity against the microbes than did the ammonium derivatives.
More research is necessary to synthesis cationic chitosan derivatives that can successfully
inhibit microbe growth and reproduction.

1.6. Previous Work
Previous research has shown the use of ammonium, phosphonium, and mPEG to
increase solubility and electrostatic interactions with DNA in aqueous solutions.
Integrating these properties into our work could potentially lead to a viable non-viral
vector suitable for gene therapy. Shi et al. 66 research group developed pH dependent
chitosan derivatives that revealed strong binding abilities between carboxymethyl
chitosan derivatives and plasmid DNA. 72 Imidazole carboxymethyl chitosan derivatives
were synthesized to increase transfection efficiency within HEK293T cells. Chitosan
derivatives bearing pH-dependent functional groups which maintained water solubility
were the precursors to formally charged chitosan derivatives. Research conducted by Tan
et al.60 used chitosan phosphonium derivatives to analyze their viability as antifungal
agents.73 Their work concluded that phosphonium derivatives could enhance anti-fungal
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activity compared to ammonium analogs, however, their work was not reproducible in
our lab. Their procedure used chloroacetic chloride that was added dropwise into an
aqueous solution that contained deacetylated chitosan and reacted for 12 hours. After
conducting this experiment ourselves several times, it was clear that these results were
not reproducible. Qian et al.37 also utilized phosphonium derivatives, but in conjunction
with HeLa cells instead of fungal cells used by Tan et al. 60 Phosphonium compounds
were observed interacting with DNA while maintaining cell viability up to 200 µg/ml.
Qian et al.37 research protocol established a successful synthesis route for coupling
carboxylic acids to primary amines without using 1% acetic acid to solubilize the
reactants. Their procedure used hydroxybenzotriazole (HOBt) and 1-ethyl-3-(3dimethylaminopropyl) carbodiimide (EDC) rather than the more commonly used Nhydroxysuccinimide (NHS), as the coupling agent. Wang et al. 68 modifications to
chitosan were similar to that of Qian et al.37 , but with slight changes to the carbon linker
between chitosan and phosphonium functional groups. This work is among many others
that show a strong interaction between phosphonium derivatives and short doublestranded DNA while maintaining mammalian cell viability. Layek et al. 69 synthesized
cationic chitosan derivatives containing hydrophobic regions that self-assemble into
micelles upon interaction with DNA. This work created increased interest for its viable
application as a gene carrier capable of efficient gene therapy. A series of work done by
Lin et al.70 and Casettari et al.71 incorporated mPEG into chitosan derivatives and
observed lower toxicity, and increased permeability, in mammalian cells. Research
conducted by Fréchet et al.72 observed that the alkyl groups on phosphonium cations play
an essential role in the overall interaction with DNA and toxicity in HeLa cells. 73,74
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Among the phosphonium groups tested, triethylphosphonium was found to be less toxic
in HeLa cells up to 350 µg/ml compared to trimethylphosphonium, which was found to
be toxic at 100 µg/ml. This work also revealed a distinction between ammonium and
phosphonium interactions with siRNA. Phosphonium complexed siRNA at much lower
concentrations than ammonium, which required up to ten times the concertation.

1.7. Purpose of Work
This research aims to synthesize ammonium and phosphonium chitosan
derivatives, seen in Figure 4, to observe and characterize their antimicrobial properties
and interaction with short double-stranded DNA and yeast cells.
In this work, ammonium and phosphonium chitosan derivatives, seen in Figure 4,
were prepared by modifying previously reported methods, to enhance complexation of
short double-stranded DNA. Tri(methyl, ethyl, and propyl)ammonium and tri(ethyl, and
phenyl)phosphonium carboxy ligands were prepared form halogenated propionic acid or
ethyl esters. The prepared ammonium and phosphonium ligands were coupled to 95%
DA chitosan using EDC and HOBt. The final cationic chitosan derivatives were
examined for their antifungal properties, and affinity towards nucleotides, using NMR,
FT-IR, CD, TGA, degree of substitution, agarose gel electrophoresis, turbidity, yeast
growth assay, florescense microscopy studies. The cationic derivatives with the most
enhanced interactions compared to unmodified chitosan were subjected to PEGylations to
observe changes in the interactions between nucleotides and yeast cells.

15

Figure 4. Ammonium, phosphonium, and PEGylated chitosan derivatives prepared in
this work.
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CHAPTER 2. EXPERIMENTAL METHODS

2.1. Materials and Instrumentation
2.1.1. Materials. Chitosan 95% deacetylated (medical grade) was purchased from
Bonding Chemical Co.. Ethyl-4-bromobutyrate, ethyl bromoacetate, chloroacetyl
chloride, 3-chloropropionyl chloride, trimethylamine, triethylamine, tripropylamine, were
purchased from Sigma-Aldrich. 1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC)
was purchased from Chem Empex. DMSO, DMSO-d6, D2 O, hydroxybenzotriazole
(HOBt), N-hydroxysuccinimide (NHS), methoxy polyethylene glycol 5000 were
purchased from Alfa Aesar. 24-mer Dickerson DNA was a gift from Dr. Gary Meints. Dr.
Kyoungtae Kim provided yeast cells. Sam Kasson, from Dr. Keiichi Yoshimatsu's lab,
supplied fluorescein isothiocyanate.
2.1.2. Nuclear magnetic resonance (NMR). Ammonium/phosphonium
carboxylic acid ligands and chitosan derivatives were subjected to 1 H NMR spectroscopy
studies using a Varian 400 MHz NMR spectrometer for data collection and third-party
ACD Labs 1D NMR processor software for data analysis. All 1 H NMR studies were
conducted at 25o C in D2 O or DMSO. D2 O was used for all chitosan derivatives, while
DMSO was used for all ammonium/phosphonium carboxylic acid ligands. All samples
prepared for 1 H NMR analysis contained 1 mg of chitosan derivative and 700 μL of
solvent. The solution was then placed into Branson 2510 ultrasonic bath for one hour to
ensure the samples were completely dissolved in the solvent, and then analyzed. The
parameters of each study were held constant with the solvent volume of 700 μL, 5 second
acquisition time, 5-second relaxation, 90o pulse angle, and auto gain control. Correction
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values were based on literature values of each solvent’s chemical shift rather than TMS.
The results of these studies can be seen in Appendix A.
2.1.3. Fourier-transform infrared spectroscopy (FT-IR). Chitosan and its
derivatives were subjected to Fourier-transform infrared spectroscopy studies to confirm
coupling of functionalized carboxylic acid ligands to N-glucosamine units. A Bruker
Vertex 70 FT-IR was used for data collection, using Bruker OPUS 7.5. software for
instrument control and data analysis. All FT-IR experiments where conducted using KBr
pellets in which 1 mg of a sample was added to 30 mg of KBr. The parameters of each
study were held constant with a wavenumber range of 4000-400 cm-1 , 2 cm-1 resolution,
100 scans, and automatic atmospheric correction. The results of these studies can be seen
in Appendix B.
2.1.4. Agarose Gel Electrophoresis. Agarose gel electrophoresis was carried out
in pH 7.4 tris acetate EDTG (TAE) buffer using 2% agarose gels, 2 µL of 80 µM
Dickerson 24-mer DNA, 5 µL of concentrated ethidium bromide, 2 µL of loading dye,
and 10 µL of chitosan derivatives. The molar cationic charge of chitosan derivatives was
obtained by comparing degree of substitution (DS) to the average N-glucosamine unit
molecular weight after carboxy ligand coupling. Molar electrostatic ratios were
determined to compare moles of cationic chitosan derivative to 24-mer Dickerson DNA
in each well, resulting in (+/-) ratios. The (+/-) ratio solutions used ranged from 16x0.25x. 2 µL of 80 µM 24-mer Dickerson DNA was added to each well, followed by a
series of solutions containing increased charge ratios using cationic chitosan derivatives.
Visualization was done using a short-range UV lamp, ethidium bromide filter camera
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lens, and Microsoft digital image capturing software. The results of these studies can be
seen in Appendix D.
2.1.5. Yeast Growth Assay. Yeast cells with an initial optical density (OD) of
0.06 were placed into a 96 well plate with increasing concertation of chitosan derivatives
ranging from 0.1 to 1000 µg/mL. The prepared samples were incubated for 24 hours at 25
oC

while shaking at 600 rpm. The OD of each well was read at 490 nm every ten minutes

over the duration of the experiment using a BioTek ELx808 microplate reader. The data
of each chitosan derivative was collected and compared using Microsoft Excel. The
results of these studies can be seen in appendix G.
2.1.6. Circular Dichroism (CD). CD Analysis was conducted using a Jasco J815 spectrometer coupled with a PFD-425s single position peltier. The samples were
loaded into a cuvette with a path length of 1mm and max volume of 400 µL. 100 µL of
10 mM phosphate-buffered saline (PBS) (pH: 7.4) was loaded into the cuvette and used
as background measurement. After the background scan was complete, 2 µL of 80 µM
Dickerson Drew Dodecamer (DDD) was added to the previous 100 µL of 10 mM PBS
sample and scanned. When both background and DDD measurements were collected, a
series of 10 µL of increasing charge ratios using cationic chitosan derivatives were added
to 100 µL of 10 mM PBS and 2 µL of 80 µM DDD. The charge ratios used ranged from
1 to 48 (+/-) and were prepared as previously established in agarose gel electrophoresis
analysis. Each sample was scanned 6 times at a speed of 50 nm/min at room temperature.
Data points were collected every 0.025 nm. The results were then analyzed using the
Jasco Data Analysis tool and overlaid in Microsoft Excel 2016. Further analysis and final
results can be found in Results and Discussion section, and Appendix E.
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2.1.7. Turbidity. Turbidity data were collected using a Varian Cary 50 UV-Vis
spectrophotometer with fiber optic probe. Turbidity instrument was unavailable for true
measurement. 1.00 mg of chitosan and its derivatives were dissolved in 5.00 mL of 1%
aqueous acetic acid. The pH was gradually increased using 0.1 M NaOH until a pH of 13
was obtained. Data was collected at various pH ranges between 3.0 and 13.0 using a
Fischer Science 810 series pH meter. The wavelength of 600 nm was used in %T
evaluation after running all samples through full range scan from 190 nm to 800 nm to
verify no conflicting signals. Turbidity results can be seen in Figure 26.
2.1.8. Thermogravimetric analysis (TGA). Thermogravimetric analysis was
conducted using a TA Instrument Q600 Thermogravimetric Analyzer. The TGA scale
was tared using two empty crucibles: one as a reference, and the second for the sample.
The sample crucible was torched with a flame and cooled before taring the instrument.
After taring, the sample crucible was then loaded with a chitosan derivative, and the
starting mass was recorded. The procedure for TGA used a ramp temperature of 20
o C/min

with an initial temperature of 25 o C and the final temperature of 600 o C. Nitrogen

was used as a purge gas flowing at 200 mL/s. Further analysis of TGA data was
conducted using TA Universal software, and the results can be found in Results and
Discussion section, and in Appendix C.
2.1.9. Fluorescence Microscopy Studies. Yeast cells were incubated overnight,
and their OD measured before analyzing with FITC tagged chitosan derivatives. 10.0 μL
of 10.0 mM FITC solution was added to 1.0 μL of 100.0 mM chitosan derivative and
shaken for one hour. The solution was then centrifuged into a pellet, and the solvent was
removed. The pellet was resuspended using acetone, vortexed for 1 minute, and then
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centrifuged down again. The FITC tagged derivatives were washed in this manner 3
times. Yeast cells (250 μL, OD 0.30) were placed in 1.0 µg/1.00 mL concentrations of
FITC tagged chitosan derivatives and incubated for 4 hours. The resulting solution after 4
hours was centrifuged down into a pellet and washed three times with glucose media to
remove free FITC tagged polymer. The final pellet was suspended in 100 μL and
vortexed for 1 min. Soon after, 2 μL of the suspended cells were removed, placed on a
glass slide, and put under a microscope. The final images were obtained using a 3i
lambda XL GFP 488 lamp for excitation, an Orca R2 wide-lens microscope for
visualization, and Slidebook Image Capturing software for digitally capturing the images.
These images can be found in the Results and Discussion, and in Appendix F.

2.2. Synthesis of Ammonium Ligands
The procedure was carried out following the protocol established by Yousuke
Ono et al.73 5.0 mL of 95% ethanol and 10.5 mmol of ethyl bromoacetate, or ethyl 4bromobutyrate, was added to a 25 mL round bottom flask. While stirring, 11.4 mmol of
trialkylamine (N(R)3 ) was addetable d dropwise to the ethanol solution. The reaction was
stirred vigorously and refluxed using a heating mantle for 15 hours. 73 The solution was
then cooled to room temperature before ethanol was evaporated using a Heidolph model
036000820 rotary evaporator, yielding a clear oily residue. Without purification, the oily
residue was dissolved in 100 mL of 2M HCl solution and refluxed for 24 hours. The
reaction was allowed to cool to room temperature before the solvent was removed at 70
oC

using the rotary evaporator.73 This resulted in an orange oily residue. The oily residue

was dissolved in 1 mL of 95 % ethanol and added dropwise into 50 mL of ethyl acetate

21

then cooled in an ice bath for 1 hour. This solution was placed on the rotary evaporator
and crystallization of cationic carboxylic acids occurred. The solvent was filtered off
using vacuum filtration, and the crystals were washed with three portions of ethyl acetate.
The final trialkyl carboxylic acid ligands were placed in a vacuum desiccator and allowed
to dry for three days. The final products were then examined using 1 H NMR
spectroscopy. The reaction scheme for the synthesis of ammonium carboxylic acid and
TEPB ligands is shown in Figure 5.

Figure 5. Reaction scheme for synthesizing ammonium/phosphonium carboxylic acid
ligands

2.3. Synthesis of Phosphonium Ligands
Freshly recrystallized chloroacetic acid, or iodopropionic acid, (5.3 mmol) was
dissolved in triethlyphosphine (5.3 mmol) and placed into a 15 mL microwave tube.73
Once fully dissolved, the tube was placed into a CEM Discover SP microwave reactor
and subjected to 35 Watts for 30 minutes under nitrogen. The reaction was then washed
with diethyl ether and dried for three days. The final products were (1-carboxymethyl)
triethylphosphonium chloride (TEPA) or (2-carboxyethyl) triethylphosphonium chloride
(TEPPr). The reaction scheme for TEPA and TEPPr can be seen in Figure 6. Synthesis of
(3-carboxypropyl)triethylphosphonium chloride (TEPB) was conducted using the
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previously established procedure for the synthesis of ammonium carboxylic acid
ligands.73

Figure 6. Reaction scheme using microwave reactor to synthesize phosphonium
acetic, or propionic, carboxylic acid ligands

2.4. Synthesis of Ammonium/Phosphonium Chitosan Derivatives
The procedure was carried out following the protocol established by Qian et al.37
1.24 mmol of ammonium/phosphonium carboxylic acid ligand was added to 0.350 g
(1.83 mmol) of EDC, and 0.350 g (2.30mmol) of HOBt in 15 mL of DMSO, and alotted
one hour to dissolve. Once completely dissolved, 0.200 g (1.24 mmol) of 95%
deacetylated chitosan was placed into the reaction mixture along with 15 mL of DI water,
stirred till homogenous, and reacted for 24 hours. After 24 hours, an additional 0.350 g of
EDC was added to the reaction mixture and stirred for 12 more hours. After 12 hours, the
reaction mixture (30 mL) was precipitated, dropwise, in 300 mL of acetone and was
shaken for 15 minutes. The acetone wash solution was then filtered using vacuum
filtration. The resulting filter cake was then returned to the original acetone wash flask
then washed with 300 mL of 95% ethanol for 15 minutes and filtered again. After
washing the product three times with ethanol, the filter cake was submerged in diethyl
ether and stirred for 15 minutes and then allowed to gravity filter for one hour followed
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by 30 minutes of air drying under vacuum filtration. The final products were
ammonium/phosphonium carboxylic acid substituted chitosan derivatives.

2.5. PEGylation of Ammonium/Phosphonium Chitosan Derivatives
Following a slightly modified protocol established in section 2.2. (shown in
Figure 7), 1.00 mmol of freshly synthesized ammonium/phosphonium chitosan derivative
(as prepared on page 25-26) was dissolved in 15 mL of DI water. In a separate 50 mL
flask, 1.0 g (0.2 mmol) of mPEG-5000 acetic acid (prepared by other graduate students
within our lab ) was dissolved in 15 mL DMSO. 0.350 g (1.83 mmol) of EDC and 0.350
g (2.30mmol) of HOBt was added to the DMSO reaction vessel and stirred for one hour
(or until completely dissolved). The two solutions were combined and stirred vigorously
for 24 hours. The DMSO/water reaction mixture was placed in a 14Kda-16Kda dialysis
membrane tube and dialyzed for three days. The dialyzed product was then lyophilized
for three days, until dry. The dry product was then crushed into fine powder and soaked
in methylene chloride for one hour to remove all un-grafted mPEG-5000 acetic acid. The
methylene chloride solution was filtered off using vacuum filtration and then washed

Figure 7. Reaction scheme using EDC and HOBt to graft mPEG-acid to chitosan.
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three more times. Then the mPEG-g-chitosan derivatives were dried at 50 o C using a
vacuum oven. The final products were PEGylated ammonium/phosphonium chitosan
derivatives.
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CHAPTER 3. RESULTS AND DISCUSSION
3.1. 1 H NMR Analysis
3.1.1. Ammonium and Phosphonium Carboxylic Acid Ligands. Ammonium
carboxylic acid ligands, phosphonium carboxylic acid ligands, and chitosan derivatives
were analyzed using 1 H NMR spectroscopy. The results of each study can be viewed in
Appendix A. The integral lines, and values, are indicated in red while the proton signals
are labeled with numbers above the spectra. After each sample was dried at 50 o C in a
vacuum oven for 12 hours, 1 mg of sample was dissolved in 700 µL of DMSO, or D2 O,
and placed into an NMR tube. All chemical shift values for ammonium carboxylic acid
ligands are compiled in Table 1.
The spectrum consisting of TMAA signals displays peaks at 4.33 ppm (2H) which
is assigned to the two protons on signal labeled 1 in Figure 8, while the peak at 3.19 ppm
(9H) corresponds to the nine protons located on the signal labeled 2. The integration
values, labeled in red, for signals 1 and 2 are proportional indicating that successful (1:1)
substitution of bromide for trimethylamine occurred. There was no acetic carboxylic acid
peak observed downfield for all acetic ligands.
The TEAA spectrum is similar to TMAA with one additional peak. The signal
furthest downfield at 4.18 ppm (2H) is assigned to the protons located on signal labeled 1
in Figure 9. When comparing the alpha carbons chemical shift (labeled 1) on TEAA and
TMAA, their value shifts from 4.33 to 4.18 ppm, displaying a delocalization of an
electron withdrawing effect brought on by increased carbon length of the
triethylammonium group. The signal observed at 3.45 ppm (6H) is assigned to six
protons located on the triethylammonium, (N +(CH2 CH3 )3 ) and is labeled 2. The signal
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Table 1. Table of synthesized ammonium carboxylic acid ligands with their
abbreviations, yield, and 1 H NMR ppm assignments using DMSO d6
Yield

1H

Ligand Name

Abbreviation

(1-Carboxymethyl)
trimethylammonium
chloride

TMAA

(73.8%) 4.33 (2H, -CH2 N +(CH3 )3 ), 3.19
(9H, -N+(CH3 )3 )

(1-Carboxymethyl)
triethylammonium
chloride

TEAA

(62.8%) 4.18 (2H, -CH2 N +(CH2 CH3 )3 ), 3.44
(6H, -N+(CH2 CH3 )3 ), 1.16 (9H, N+(CH2 CH3 )3

(1-Carboxymethyl)
tripropylammonium
chloride

TPAA

(70.3%) 3.29 (2H, HO 2 CCH2 -), 2.96 (6H, N+(CH2 CH2 CH3 )3 ), 1.62 (6H, N+(CH2 CH2 CH3 )3 ), 0.85 (9H, N+(CH2 CH2 CH3 )3

(3-Carboxypropyl)
trimethylammonium
chloride

TMAB

(88.9%) 12.31 (1H, HO2 CCH2 -), 3.01 (9H, CH2 CH2 CH2 N(CH3 )3 ), 2.71 (2H, CH2 CH2 CH2 N+(CH3 )3 ), 2.26 (2H, CH2 CH2 CH2 N+(CH3 )3 ), 1.88 (2H, CH2 CH2 CH2 N+(CH3 )3

(3-Carboxypropyl)
triethylammonium
chloride

TEAB

(82.6%) 12.31 (1H, HO2 CCH2 -), 3.20 (9H, N+(CH2 CH3 )3 ), 3.07 (2H, CH2 N+(CH2 CH3 )3 ), 2.31 (2H, CH2 CH2 CH2 N+-), 1.75 (2H, CH2 CH2 CH2 N+-), 1.13 (2H, N+(CH2 CH2 )3

(3-Carboxypropyl)
tripropylammonium
chloride

TPAB

(39.2%) 12.31 (1H, HO2 CCH2 -), 3.20 (6H, N+(CH2 CH2 CH3 )3 ), 3.07 (2H, CH2 N+(CH2 CH2 CH3 )3 ), 2.31 (2H, CH2 CH2 CH2 N+-), 1.75 (2H, CH2 CH2 CH2 N+- ), 1.13 (9H, N+(CH2 CH2 CH3 )3
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NMR ppm DMSO-d6

observed at 1.16 ppm (9H) is assigned to the nine protons found on
triethylammonium, (N +(CH2 CH3 )3 ) and is labeled 3. The integration values for these
signals are labeled in red in Figure 9. These values are (1:1) indicating proportional
substitution of bromide for triethylamine.
The signals observed for TPAA in Figure 10, again, are similar to the other
ammonium acetic acid ligands prepared. The signal at 3.29 ppm (2H) corresponds with
the protons found on the alpha carbon, labeled 1. This signal demonstrates a continued
delocalization of electron withdrawing effect as the alkyl substituents lengthen. The
signal observed at 2.96 ppm (6H) is assigned to the protons labeled 2, followed by the
signal at 1.62 (6H)ppm and is labeled 3. The nine protons associated with the three
methyl groups on signal 4 appear at 0.85 ppm (9H). The integration values for TPAB are
shown in Figure 10, and again, these values are proportional (1:1) indicating no other
impurities are present in the NMR sample.
The spectrum of TMAB is shown in Figure 11. The proton signal found at 12.31
ppm (1H) is assigned to the carboxylic acid grouped labeled 5. The signal labeled 3 is
located at 3.26 ppm (2H) and is the CH2 closest to the carboxy group. The peak observed
at 3.01 ppm (9H) is assigned to the nine protons located on the signal labeled 4. The
signals for protons 2 and 3 are located at 2.26-1.86 ppm (4H).
The spectrum of TEAB, shown in Figure 12, displays a carboxylic acid peak
labeled 6 at 12.30 ppm (1H). The chemical shift values of the carbon chain found on
TEAB, are similar to that of TMAB and can be assigned accordingly 3.09 ppm (2H label
3), 2.31 ppm (2H label 1), 1.75 ppm (2H label 2). However, unlike that of TMAB, TEAB
has one new peak emerge at 3.20 ppm (6H label 4) that is assigned to the -CH2 - closest to
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Figure 8. Integrated 1 H
NMR of TMAA.

Figure 9. Integrated 1 H
NMR of TEAA.
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Figure 10. integrated 1 H
NMR of TPAA

N +. The nine protons assigned to the methyl groups are labeled 5 and are observed at 1.13
ppm (9H label 5). The butanoic ligands display similar delocalization of the electron
withdrawing effect like that of acetic acid ligands.
The proton signals for TPAB were similar to that of TEAB and TMAB except for
the addition of one new peak. Like that of TEAB and TMAB, the butanoic carbon chain
signals are located at 3.09 ppm, 2.29ppm, and 1.77 ppm corresponding to labels 3, 1, and
2, shown in Figure 13. A clear carboxylic acid peak is present at 12.31 ppm (1H label 7)
indicating successful ester hydrolysis. The peak labeled 4, 5, and 6 are the ammonium
tripropyl group and have chemicals shift values of 3.12 ppm (6H, label 4), 1.60 ppm (6H,
label 5), and 0.85 ppm (9H, label 6).
The phosphonium carboxylic acid ligands were examined in the same way and
values are found in table 2. TEPA proton signals were examined and labeled 1, 2, and 3
shown in Figure 14. Label 1 is assigned to the protons located between the carboxyl and
phosphonium groups and has a chemical shift value of 3.75 ppm (2H, d). The
protonsignals for the triethyl group bound to P + have chemical shift values of (6H) and
(9H) and are labeled 2 and 3, respectively.
TEPPr proton signals were examined and labeled 1, 2, 3, and 4, shown in Figure
15. Labels 1 and 2 are assigned to the protons located between the carboxyl and
phosphonium groups and have a chemical shift value of 2.59 ppm (2H) and 2.39 ppm
(2H). The proton signals for the triethyl group bound to P + have chemical shift values of
2.23 ppm (6H) and 1.10 ppm(9H) and are labeled 3 and 4, respectively. The signal
located at 12.59 ppm (1H) is labeled 5 and is assigned to the carboxylic acid.
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Table 2. Table of synthesized phosphonium carboxylic acid ligands with their
abbreviations, yield, and 1H NMR ppm assignments using DMSOd6
Ligand Name
(1-Carboxymethyl)
triethylphosphonium
chloride
(2-Carboxyethyl)
triethylphosphonium
chloride

(3-Carboxypropyl)
triethylphosphonium
chloride

Abbreviation

Yield

1H

NMR ppm DMSOd6

TEPA

3.75 (2H, -H2 P+(CH2 CH3)3 ), 2.30
(6H, HO 2 CCH2 P+(CH2 CH3)3 ), 1.10
90.0%
(9H, -P+(CH2 CH3)3

TEPPr

12.58 (1H, HO2 CCH2 -), 2.55 (2H, CH2 CH2 P+-), 2.39 (2H, -CH2
P+(CH2 CH3 )3 ), 2.23 (6H, 75.3% +
P (CH2 CH3 )3 ), 1.08 (9H, P+(CH2 CH3 )3

TEPB

12.16 (1H, HO2 CCH2 CH2 -), 2.36
(2H, HO 2 CCH2 CH2 CH2 -), 2.26 (2H, CH2 P+(CH2 CH3 )3 ), 2.22 (6H, 76.1% P+(CH2 CH3 )3 ), 1.67 (2H, CH2 CH2 P+(CH2 CH3 )3 ), 1.08 (9H, P+(CH2 CH3 )3
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Figure 11. 1 H NMR
spectrum of TMAB

Figure 12. 1 H NMR
spectrum of TEAB
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Figure 13. 1 H NMR
spectrum of TPAB

The spectrum of TEPB, shown in Figure 16, was examined and labeled 1, 2, 3, 4
and 5. Labels 1, 2, and 3 are assigned to the protons located between the carboxyl and
phosphonium groups and have a chemical shift value at 2.36 ppm (2H), 2.16 ppm (2H),
and 1.67 ppm (2H). The proton signals for the triethyl group bound to P+ have chemical
shift values of 2.2 ppm (6H) and 1.10 ppm(9H) and are labeled 4 and 5, respectively. The
signal located at 12.31 ppm (1H) is labeled 6 and is assigned to the carboxylic acid.
3.1.2 Ammonium and Phosphonium Chitosan Derivatives. All synthesized
derivatives displayed characteristic chitosan signals as evidenced by the broad peaks
located from 4.00-3.30 ppm, shown in Figure 17, and they are assigned to the protons
found on Chitosans glucosamine ring (labeled C2 -C6 ). All ammonium and phosphonium
chitosan derivatives ppm values are shown in Table 3 and 4.
TMAB-CS’s -CH2 - signals labeled b, c, and d are found between the amide and
ammonium group and have a chemical shift values of 2.29 ppm (2H), 1.96 ppm (2H), and
3.21 ppm (2H), as shown in Figure 17. The proton signals for the trimethyl group found
on N + have a chemical shift value of 2.96 ppm (9H) and are labeled e.
For TEAB-CS, the -CH2 - signals, also labeled b, c, and d, are found between the
amide and ammonium group and have a chemical shift values of 2.28 ppm (2H), 1.85
ppm (2H), and 3.04 ppm (2H) ), as shown in Figure 17. The proton signals for the triethyl
group found on N + have chemical shift values of 3.15 ppm (6H) and 1.11 ppm (9H) and
are labeled e and f.
For TPAB-CS, the -CH2 - signals, once more labeled b, c, and d, are found
between the amide and ammonium group and have a chemical shift values of 2.26 ppm
(2H), 1.85 ppm (2H), and 2.74 ppm (2H) ), as shown in Figure 17 The proton signals for
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Figure 14. 1 H NMR
spectrum of TEPA

Figure 15. 1 H NMR
spectrum of TEPPr

34

Figure 16. 1 H NMR
spectrum of TEPB

Table 3. Table of synthesized ammonium chitosan derivatives with their
abbreviations, yield (DS), and 1H NMR ppm assignments using D2O
Compound Name
2-(N-4trimethylammonium)
butanamide chitosan
chloride

2-(N-4triethylammonium)
butanamide chitosan
chloride

2-(N-4tripropylammonium)
butanamide chitosan
chloride

Abbreviation

TMAB-CS

TEAB-CS

TPAB-CS

DS

50.0%

1H

NMR ppm D2 O

4.45 (1H, anomeric H), 3.80-3.30
(6H, C2 -C6 H’s), 3.21 (2H, CH2 CH2 N+(CH3 )), 2.98 (9H, CH2 CH2 N +(CH3 )3 ), 2.29 (2H, OCH2 CH2 CH2 N+(CH3 )), 1.96 (2H,
-CH2 CH2 N+(CH3 ).

43.0%

4.43 (1H, anomeric H), 4.0-3.25
(6H, C2 -C6 H’s), 3.15 (6H, N +(CH2 CH3)3 ), 3.04 (2H, CH2 CH2 N+(CH2 CH3)3 ), 2.66 (12H, -2H-NHCOCH2 -), 2.28 (2H, OCH2 CH2 CH2 N+- , 1.84 (2H, CH2 CH2 N+( CH2 CH3)3, 1.11 (9H, CH2 CH2 N +( CH2 CH3)3

26.0%

4.48 (1H, C1 -Anomaric H), 4.03.25 (6H, C2 -C6 H’s), 3.04 (6H, N +(CH2 CH2 CH3 )3 ), 2.74 (2H, CH2 N+(CH2 CH2 CH3 )3 ) , 2.26 (2H,
-CH2 CH2 CH2 N+-), 1.85 (2H, CH2 CH2 N+-), 1.55 (6H, N +(CH2 CH2 CH3 )3 ), 0.79 (9H, N +(CH2 CH2 CH3 )3
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Table 4. Table of synthesized phosphonium chitosan derivatives with their
abbreviations, yield (DS), and 1H NMR ppm assignments using D2O
Compound Name
2-(N-3triethylphosphonium)
propionamide
chitosan chloride

2-(N-4triethylphosphonium)
butanamide chitosan
chloride

2-(N-5triphenylphosphoniu
m) pentanamide
chitosan chloride

Abbreviation

TEPPr-CS

TEPB-CS

TPPP-CS

Yield

19.0%

1H

NMR ppm D2 O

4.48 (1H, anomeric H), 4.0-2.66
(6H, C2 -C6 H’s,2H-NH), 2.55 (2H,
-CH2 CH2 N+(CH2 CH3 )3 ), 2.38 (2H,
-CH2 N+(CH2 CH3 )3 ) , 2.11 (6H, CH2 N +(CH2 CH3 )3 ), 1.09 (9H, -CH2
N +(CH2 CH3 )3

21.0%

4.82 (1H, anomeric H), 4.0-2.66
(6H, C2 -C6 H’s ,2H-NH), 2.35 (2H,
-OCH2 CH2 CH2 N + -), 2.07 (6H, N +(CH2 CH3 )3 ) , 2.07 (2H, CH2 N+(CH2 CH3 )3 ), 1.75 (2H, CH2 CH2 N+(CH2 CH3 )3 ), 1.08 (9H, N +(CH2 CH3 )3

42.0%

7.65-7.50 (15H, P+Ph3 -CH2 CH2 -),
4.39 (1H, anomeric H), 4.0-2.66
(6H, C2 -C6 H’s ,2H-NH), 3.13 (2H,
P+Ph3 -CH2 CH2 -), 2.16 (2H, P+Ph3 CH2 CH2 CH2 CH2 -), 1.60 (4H,
P+Ph3 -CH2 CH2 CH2 -)
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Figure 17. 1 H NMR spectra of 1) TMAB-CS, 2) TEAB-CS, 3) TPAB-CS, 4) TEPBCS, 5) TEPPr-CS, and 6) TPPP-CS, using D2O.
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the tripropyl group found on N + have chemical shift values of 3.04 ppm (6H), 1.55 ppm
(6H), and 0.79 ppm (9H) and are labeled e, f, and g.
The phosphonium derivatives display similar chemical shift values compared to
ammonium derivatives except for the -CH2 - located on the triethyl group attached to P +.
These -CH2 - protons experience far less deshielding from P + compared to N + and are
observed having a 1.04 ppm difference in chemical shift value. As for TPPP-CS
derivative, the 1 H NMR spectrum and ppm values are previously reported in scientific
literature, can be seen in Table 2 and Figure 17.
For TEPPr-CS, the -CH2 - signals labeled b, and c are found between the amide
and phosphonium group and have chemical shift values of 2.55 ppm (2H), and 2.38 ppm
(2H), as shown in Figure 17. The proton signals for the triethyl group found on P + have
chemical shift values of 2.11 ppm (6H) and 1.08 ppm (9H) and are labeled d and e.
For TEPB-CS, the -CH2 - signals, also labeled b, c, and d, are found between the
amide and ammonium group and have chemical shift values of 2.35 ppm (2H), 1.75 ppm
(2H), and 2.07 ppm (2H) ), as shown in Figure 17 The proton signals for the triethyl
group found on P+ have chemical shift values of 2.07 ppm (6H) and 1.08 ppm (9H) and
are labeled e and f.
3.1.3 PEGylated Ammonium, and Phosphonium, Chitosan Derivatives.
Compound TEAB-CS, TEPB-CS, or TPPP-CS was reacted with mPEG-acid (MW:
5000), EDC, and HOBt to synthesis PEGylated chitosan derivatives. TEPB-CS and
TEAB-CS were selected because they are direct analogs of each other and can provide a
direct comparison between ammonium and phosphonium interaction before and after
PEGylation. TPPP-CS already reported in scientific literature was found to be toxic to
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mammalian cells by Quian et al. 37 and was selected to undergo PEGylation to evaluate
PEGs ability to lower toxicity. All 1 H NMR spectra of PEGylated compounds have the
same chemical shift values as their non-PEGylated derivatives, as shown in Table 5,
except for PEG polymer chain located at 3.55 ppm (448H) and its methoxy at 3.20 ppm
(3H). PEGylated 1 H NMR spectra can be seen in Figure 18.
3.1.4 Discussion. 1 H NMR was conducted for confirmation of successful
ammonium/phosphonium carboxy ligand coupling to chitosan. EDC and HOBt were
observed in 1 H NMR spectra until after the third wash cycle. Accurate integrations and
spectra comparisons could be analyzed once EDC and HOBt were successfully removed.
Integration values and peak assignments became more difficult to analyze after coupling
due to the loss of resolution and peak broadening caused by the increased polydispersity
and chitosan’s long polymer backbone. All peak assignments are found in the
experimental section, and in Appendix A. Ammonium carboxy ligands displayed a much
higher deshielding effect than did phosphonium groups. In the case of triethylammonium
carboxy ligands, the CH2 associated with N +(CH2 CH3 )3 was observed at 3.15 ppm; and
displays more of an inductive effect from its neighboring N + than that of its P+ analog.
Comparing the same CH2 found in P+(CH2 CH3 )3 , the chemical shift is more upfield at 2.0
ppm, displaying less of an inductive effect on neighboring carbons adjacent to P+, and
leading to a more localized cationic charge. The localization of cationic charge is
expected to be more observable in future studies, including agarose gel electrophoresis.
1H

NMR was only conducted on ammonium/phosphonium propionic, butanoic, and

pentanoic chitosan derivatives. Ammonium/phosphonium acetic acid chitosan derivatives
proved to be unsuccessful in coupling to chitosan with EDC and HOBt. Although acetic
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Table 5. Table of PEGylated ammonium, or phosphonium, chitosan derivatives with
their abbreviations, yield (DS), and 1H NMR ppm assignments using D2O.
Compound Name

2-(N-4triethylphosphonium)
butanamide mPEG-gchitosan chloride

2-(N-4triethylammonium)
butanamide mPEG-gchitosan chloride

2-(N-5triphenylphosphonium)
pentanamide mPEG-gchitosan chloride

Abbreviation

TEPB-mPEGCS

TEABmPEG-CS

TPPPmPEG-CS

DS

1H

NMR ppm D 2 O

1.67%

4.82 (1H, anomeric H), 4.0-2.66
(6H, C2 -C6 H’s ,2H-NH), 3.55
(mPEG backbone), 3.23 (3H, OCH3 ), 2.35 (2H, CH2 CH2 CH2 P+-), 2.07 (6H, CH2 P+(CH2 CH3 )3 ) , 2.07 (2H, CH2 CH2 P+(CH2 CH3 )3 ), 1.75 (2H,
-CH2 CH2 P+(CH2 CH3 )3 ), 1.08
(9H, -CH2 P+(CH2 CH3 )3

5.73%

4.43 (1H, anomeric H), 4.0-3.25
(6H, C2 -C6 H’s), 3.55 (mPEG
backbone), 3.23 (3H, -OCH3 )
3.15 (2H, -N +(CH2 CH3 )3 ), 3.04
(6H, -CH2 CH2 N+(CH2 CH3 )3 ),
2.66 (1-2H, CH2 CH2 N+(CH2 CH3 )3 ), 2.28 (2H,
-CH2 CH2 CH2 N +( CH2 CH3 )3, 1.84
(2H, -CH2 CH2 N +( CH2 CH3 )3,
1.11 (9H, -CH2 N +( CH2 CH3 )3

2.76%

7.65-7.50 (15H, P+Ph3CH2 CH2 CH2 CH2 -), 4.39 (1H,
anomeric H), 4.0-2.66 (6H, C2 C6 H’s ,2H-NH), 3.55 (mPEG
backbone), 3.23 (3H, -OCH3 ),
3.13 (2H, P+-CH2 CH2 CH2 CH2 -),
2.16 (2H, Ph3 -CH2 CH2 CH2 CH2 -),
1.60 (4H, Ph3 -CH2 CH2 CH2 CH2 -)
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Figure 18. 1 H NMR spectra of 1) TEAB-mPEG-g-CS, 2) TEPB-mPEG-g-CS, and 3)
TPPP-mPEG-g-CS, using D2O
acid ligands are small, the reactive carboxyl group is sterically hindered to a significant
degree by the ammonium/phosphonium group directly adjacent. More efficient coupling
was observed as the carbon chain increases on the carboxy ligand, as seen in Table 6.
Variations in ammonium alkyl groups also displayed a correlation in degree of
substitution. All substituion reactions contained same ratio of ligand to chitosan and
reaction conditions. TMAB-CS had the highest coupling efficiency (DS=50%), compared
to that of TEAB-CS and TPAB-CS, due to its long carbon chain and decreased steric
hindrance from the trimethyl groups. Compared to TMAB-CS and TEAB-CS, TPAB-CS
displayed the lowest coupling efficiency ( DS=23%) as its bulky propyl substituents
created increased steric hindrance.
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Table 6. Calculated degree of substitution (DS) for all chitosan derivatives
Degree of
Substitution

Compound
2-(N-3-triethylphosphonium) propionamide chitosan chloride
(TEPPr-CS)

19% P+

2-(N-4-triethylphosphonium) butanamide chitosan chloride
(TEPB-CS)

21% P+

2-(N-5-triphenylphosphonium) pentanamide chitosan chloride
(TPPP-CS)

42% P+

2-(N-4-trimethylammonium) butanamide chitosan chloride
(TMAB-CS)

50% N +

2-(N-4-triethylammonium) butanamide chitosan chloride
(TEAB-CS)

43% N +

2-(N-4-tripropylammonium) butanamide chitosan chloride
(TPAB-CS)

26% N +

2-(N-4-triethylphosphonium) butanamide mPEG-g-chitosan
chloride

1.6% mPEG

(TEPB-mPEG-CS)
2-(N-4-triethylammonium) butanamide mPEG-g-chitosan
chloride

5.73% mPEG

(TEAB-mPEG-CS)
2-(N-5-triphenylphosphonium) pentanamide mPEG-g-chitosan
chloride
(TPPP-mPEG-CS)
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2.76% mPEG

3.2. FT-IR Analysis
FT-IR analysis was conducted on all ammonium and phosphonium chitosan
derivatives to examine changes in spectra after cationic carboxyl substitution.
Characteristic peaks corresponding to amide I and II formation observed near
wavenumbers 1650 cm-1 and 1550 cm-1 were found for both ammonium and
phosphonium derivatives as shown in Figure 19. C-N+ stretching was observed in all
ammonium derivatives near wavenumber 1480 cm-1 and was consistent with C-N+ values
found by Tan et al.67 C-P+ stretching was observed in all phosphonium derivatives
between wavenumbers 1450 and 1410 cm-1 and was consistent with C-P+ values found by
Qian et al.37 Characteristic wavenumbers for chitosan are observed at 3260 cm-1 and are
assigned to the hydroxyl and amino groups found on carbons 3 and 6. C-H stretching was

N+

Figure 19. FT-IR spectra of TMAB-CS, TEAB-CS, TPAB-CS, TEPB-CS, TEPPr-CS,
and TPPP-CS, showing C-P+ and C-N+ for synthesized chitosan derivatives.
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observed near wavenumber 2880 cm-1 for all chitosan derivatives. For all chitosan
derivatives, an amide I signal associated with C=O stretching vibration is observed near
wavenumber 1650 cm-1 , while an amide II signal associated with N-H bending vibrations
appears near wavenumber 1540 cm-1 .
Strong C-O stretching frequencies associated to carbons 1, 3, 4, 5, and 6 were observed
near wavenumber 1060 cm-1 . PEGylated derivatives’ additional C-H, and C-O stretching
causes a dramatic increase in intensity near wavenumbers 2867 cm-1 and 1060 cm-1 , as
shown in Apendix B. Characteristic chitosan derivative peaks were still observable after
PEGylation indicating a low percentage of mPEG-acid substitution.

3.3. Degree of Substitution
Further characterization of chitosan and its derivatives relies on obtaining the
degree of substitution (DS) of ammonium/phosphonium carboxy ligand and mPEG (MW:
5000) acid to chitosan. The degree to which these derivatives are substituted affects their
overall interaction with biological molecules. Ammonium/phosphonium ligands promote
higher electrostatic interactions due to their formally-charged nitrogen or phosphorous.
Adapting DS calculation protocol from Jaidee et al. 44 , 1 H NMR was used to obtain final
DS values. Using 1 H NMR spectra, the degree of substitution can be obtained by
comparing two independent integration values and the number of protons contributing to
those values.49 In Figure 20, we found the acetyl groups DS by comparing both chitosans,
and acetyl groups, integral values to their associated protons. Dividing the acetyl group’s
integration value by the number of protons associated to that signal (3 protons), we obtain
the integration value of 1 acetyl proton. Likewise, Dividing the chitosan polymer
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3.00 ÷ 3

DS = 128 .59 ÷6 × 100 = 4.66 % Acetylated

DS =

3.00 ÷ 3
128 .59 ÷6

× 100 = 4.66 % Acetylated

Figure 20. Calculation of degree of substitution (DS) using staring material 95%
DA chitosan. Integral lines are in red and their values below the spectrum
integration value by the number of protons associated to that signal (6 protons, excluding
the hydrogen attached to anomeric carbon), we obtain the integration value of 1 chitosan
proton. Then dividing the 1 acetyl proton value by the 1 chitosan proton value and
multiplying it by 100, gives us the degree of substitution of acetyl groups found on
chitosan. Following the equation set forth above and also found in Figure 21, we obtained
DS for our starting material. The acetyl integration value of 3.00 should be divided by 3,
(for there are three protons found on acetyl groups) leaving a value of 1. Then chitosans
integration value of 128.59 should be divided by 6, (for the sum of protons on carbons
C2 -C6 is 6) leaving 21.43. Finally, dividing acetyls value of 1 by chitosans value of 21.43
and multiplying by 100, we obtain a DS=4.66%. The DS percent value represents the
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percent of acetyl groups coupled to amino groups on chitosan. Thus, 4.66% of our
starting material is acetylated. The chitosan shown in Figure 20 was purchased as 95%
deacetylated chitosan from Bonding Chemical company. 66 Comparing these two values
of acetylation from our calculations and Bonding Company analysis, we were able to
obtain the same degree of accuracy of substitution up to (0.34%). 66
mPEG DS was calculated following an altered mathematical procedure is shown
in Figure 22. DS values of PEGylated chitosan derivatives needed to incorporate the DS
of the previous reaction product before the DS of the mPEG could be evaluated. The
equation given in Figure 21 can be rearranged to solve for chitosans integration value
using the previously calculated DS for that particular ammonium/phosphonium
derivative, as seen in Figure 22. After calculating the integration value for chitosan, we
can subtract this value from the overlapping integration values, of mPEG and chitosan, to
isolate mPEG’s integration value. This value can be plugged in the equation found in
Figure 21 to determine the DS of PEGyalted derivatives.

Figure 21. Equation used for calculating degree of substitution where Is is, integrated
signal value for substituted ligand, Hs is number of protons associated to substituted
ligand, and Ichitosan is the integrated signal value for chitosan protons (C2-C6 and CH2 OH)
The DS values obtained for both PEGylated and non-PEGylated derivatives were
used in both CD and agarose gel electrophoresis. These DS values were used to calculate
moles of positive charge for each chitosan derivative and their average molecular weight
per unit after substitution reactions. Using these calculated values, we were able to obtain
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Figure 22. equation used for calculating degree of substitution of PEGylated
derivatives, where Is is, integrated signal value for substituted ligand, Hs is number of
protons associated to substituted ligand, and Ichitosan is the integrated signal value
for chitosan. After finding ∑ Ichitosan (2.6-4.0 ppm) this value can be subtracted from the
integration value for the PEGylated spectrum to isolate just the mPEGs integration
value.
accurate charge to charge ratios for determining ammonium, and phosphonium,
derivatives’ affinity to Dickerson Drew Dodecamer (DDD) B-form DNA.

3.4. Agarose Gel Electrophoresis
Agarose gel electrophoresis was used to examine ammonium and phosphonium
chitosan derivatives’ ability to complex DDD B-form DNA. The concentration of DDD
was calculated using the absorbance value from 260 nm collected by Varian Cary 50 UVVis spectrophotometer and its extinction coefficient of 1.11 × 105 M−1 cm−1 at 25o
C.Using 24-mer DDD B-form DNA (consisting of 24 negatively charged phosphate
groups), we were able to evaluate interactions using ammonium/phosphonium chitosan
derivatives. All ratios established for electrophoresis are a charge to charge ratio
determined by DS of each chitosan derivative. These ratios are written in (n)X notation,
were “n” is whole number multiplied by 1 to 1 ratio of positive to negative charge (+/-).
For all DNA-ammonium chitosan derivative complexes exceeding a ratio of 2X, we were
able to observe complete complexation of DNA, evidenced by the fluorescence staying in
the starting wells. Moving from the 2X ratio towards 0.25, we can observe a signal for
free, uncomplexed DNA. When comparing ammonium chitosan derivatives affinities at
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2X charge ratio, we can observe clear differences in cationic interaction between the
different ammonium groups. At a charge ratio of 2X, TPAB-CS displayed the least
affinity to DDD DNA, compared to TMAB-CS and TEAB-CS. TEAB-CS appeared to
have the most effective interactions with DNA as evidenced by complete complexation at
a charge ratio of 2X compared to TMAB-CS and TPAB-CS charge ratios of 4X, as seen
in Figure 23. Attention should be drawn to the florescence that remain in the wells after
complete complexation at 4X, 8X, and 16X. In the case of TPAB-CS, the fullycomplexed DNA in 4X charge ratio appeared to be pushed towards the front of the well,
as seen in Figure 23. As for the wells containing charge ratios of 8X and 16X, the

Figure 23. Agarose gel electrophoresis results of TMAB-CS, TEAB-CS, TPAB-CS,
and TEPB-CS. Wells are in charge ratios of 1: 16x, 2: 8x, 3: 4x, 4: 2x, 5: 1x, 6: 0.5x,
7: 0.25x, 8: Control
florescence can be observed drawn toward the back of the well. Completely complexed
DNA was observed in the starting wells having an over all complexation charge, as
evidenced by their postion in the startings wells. In the case of phosphonium derivatives,
there were not only differing results from the ammonium groups, but the phosphonium
groups had different outcomes amongst themselves. TEPPr-CS appears less soluble
compared to TEPB-CS leading to a dramatic loss of complexation of DDD DNA across
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all charge ratios. Reaction conditions for TEPPr and chitosan coupling would have to be
improved to increase solubility and the efficiency of DNA complexation at lower charge
ratios. TPPP-CS displayed improved results when compared to ammonium derivatives;
complete complexation occurs at a charge ratio of 2X; leaving little-to-no signal at
concentration 1X. TEPB-CS had a more effective interaction than all other derivatives
tested. Complete complexation using TEPB-CS occurred at a charge ratio of 1X. TEPBCS had a higher affinity for DDD DNA at charge ratios 0.5 and 0.25X when compared to
all other chitosan derivatives. Due to a more localized charge, TEPB-CS complexes DNA
more efficiently. This increase in efficiency could make phosphonium chitosan
derivatives viable candidates for gene therapy.
PEGylation of these compounds resulted in a severe loss of electrostatic
interaction between chitosan derivatives and DNA, as seen in Figure 24. After
PEGylation, TPPP-mPEG-g-CS and TEAB-mPEG-g-CS suffered a drastic loss in
interaction with DDD compared to their previous un-PEGylated derivatives. The large
size of mPEG-5000 increases steric hindrance to the already-bulky trialkyl chitosan
derivatives. However, PEGylation of TEPB-CS resulted in only a slight loss of
interaction with DDD. The DS for TEPB-CS was half that of TEAB-CS, and yet
PEGylated TEPB-CS maintained high complexation of DDD DNA compared to
PEGylated TEAB-CS. Although the PEGylated ammonium derivatives lack the same
efficiency of un-PEGylated derivatives, electrostatic interaction leading to complete
complexation can still be observed.
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Figure 24. Agarose gel electrophoresis results of TEAB-mPEG-g-CS and TEPBmPEG-g-CS. Wells are in charge ratios of 1: 16x, 2: 8x, 3: 4x, 4: 2x, 5: 1x, 6: 0.5x,
7: 0.25x, 8: Control

3.5. Turbidity
Chitosan derivatives were analyzed for pH-dependent solubility using a Varian
Cary 50 UV-Vis spectrophotometer at 600 nm. Values of %T were collected over an
increasing pH range from 3-13. The data points for each study were plotted on a graph
and can be seen in Figure 25. Turbidity results are used to determine the potential
viability of chitosan derivatives that can remain soluble long-term in vivo. During the
analysis, TPPP-mPEG-g-CS was the only derivative with a noticeable decrease in %T
after pH 7. Although the decrease was gradual, the derivative did not aggregate or fall out
of solution. TEPPr-CS exhibited a steady overall %T that was lower than all other
derivatives tested, which may be correlated to the poor interaction with DDD during
agarose gel electrophoresis. The turbidity analysis displayed a lack of pH-dependent
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solubility in the chitosan derivatives, ensuring that our products are not just protonated
chitosan species.

Figure 25. Turbidity analysis of all synthesized chitosan derivatives evaluated using
%T at 600 nm. With an initial pH of 3, 0.1 M NaOH was added to increase pH till a
value of 13 was obtained
3.6. Thermogravimetric analysis (TGA) and Differential Thermogravimetric (DTG)
It is known that intramolecular and intermolecular hydrogen bonding stabilizes
fully acetylated chitin and 95% DA chitosan. most of these interactions are lost in
carboxy substituted chitosan derivaitves.66 It has been well established that chitosan
derivatives with increasing DS exhibit lower intermolecular stability when compared to
low DS derivatives.66 Ammonium and phosphonium chitosan derivatives were analyzed
using TGA, and their results displayed a clear correlation between increased DS and
decreased thermal stability which were consistent with literature findings.67
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Thermogravimetric analysis was conducted using a TA Instrument Q600
Thermogravimetric analyzer on all chitosan derivatives to evaluate thermal stability after
ammonium, phosphonium, and mPEG (MW: 5000) substitutions. All samples were
subjected to thermal degradation starting at room temperature and ending at 600 o C using
a ramp rate of 20 o C/min. Although the stability is lower due to the loss of hydrogen
bonding interactions, the degradation process takes on new phases as different ligands are
coupled to chitosan. Unmodified chitosan TGA displayed initial degradation beginning at
265 o C, followed by a smooth decline until no further degradation phases were observed.
The degradation phases for ammonium and phosphonium chitosan derivatives were close
together making separate phases harder to distinguish. The TGA results for chitosan and
its derivatives were converted to differential thermogravimetric (DTG) (%/o C) for more
accurate comparisons.
Changes in chitosan derivatives’ stability due to altered substituents is readily
observed using DTG rather than unmodified TGA. DTG peaks indicate a high loss in
weight % at a particular temperature. Using DTG, single- or multi-phase degradation is
more easily observed compared to the cluttered signal of TGA, as seen in Figures 26 and
27. All DTG results display an initial phase between 25-100 o C due to loss of water
adsorbed to the starting material, which is not considered to be a degradation phase.
Chitosan follows a single-phase degradation process displaying no secondary
stabilization structure. TEAB-CS displayed a degradation process similar like that of
chitosan where only one phase is observed. However, TEAB-CS’s degradation begins at
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Figure 26. DTG of non-PEGylated ammonium, and phosphonium, chitosan
derivatives was used to examine change in stability of chitosan’s polymer chain after
carboxylic coupling reaction
223 o C, which is 42 o C less than unmodified chitosan; indicating loss of intermolecular
stabilization. Both TMAB-CS and TPAB-CS displayed a two-phase degradation process.
Their first phases begin at 227 o C and 216 o C, indicating a loss of stabilization when
compared to unsubstituted chitosan. Their second phases began at 239 o C and 259 o C and
can be attributed to the ammonium ligands substitution. TEPB-CS displayed three phases
of degradation and the lowest overall thermal stability. The first phase of TEPB-CS
began at 205 o C which is significantly lower than that of unsubstituted chitosan beginning
at 265 o C. TEAB-CS, TEPB-CS, and TPPP-CS were PEGylated to challenge the
hypothesis of increased stability in mPEG grafted polymers.
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Figure 27. DTG of PEGylated TEAB-CS, and TEPB-CS, derivative used to examine
the change in stability of chitosan’s polymer chain after carboxylic and mPEG
coupling reactions
There was an overall increase in stability, but not to the chitosan derivative’ s main
polymer chain. Phase 1 for compounds TEAB-CS, TEPB-CS, and TPPP-CS still had
decreased degradation temperatures of 193 o C, 229 o C, and 208 o C, respectively.
However, these PEGylated derivatives displayed an additional phase beginning at 344 o
C, 310 o C, and 338 o C; which can be assigned to the degradation of the mPEG backbone.
Although there was increased stability with more of the weight percent being preserved
until higher temperature, this was due only to the addition of mPEG (MW: 5000), and not
to the stability of chitosan derivatives. Ammonium and phosphonium chitosan derivatives
were analyzed using TGA, and DTG, and their results of the first degradation phase
demonstrates a correlation between increased DS and decreased thermal stability.67
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3.7. Circular Dichroism (CD)
CD analysis was conducted to observe electrostatic interaction with the
nucleotides found in DDD DNA and chitosan derivatives. Jasco J-815 CD spectrometer
evaluated the effects of chitosan and its derivatives on DDD's secondary structure, Bform double-stranded DNA at 25 o C. The charge ratios used for CD analysis were
prepared in the same manner as agarose gel electrophoresis. Unmodified chitosan and its
derivatives do not produce a signal in the wavelengths being investigated. The positive
and negative ellipticities of DDD are centered around 280 nm and 260 nm, and are in
concordance with literature findings for B-form DNA.68-70 In Figure 28, the chitosan
derivatives were examined at a charge ratio of 4x. It is at this charge ratio we examined
complete complexation of DNA in all derivatives. The greatest loss of B-form
comformational normality was oberved with TPAB-CS. As charge ratios amongst the
independent studies are increased, the loss of B-form conformational state is observed
due to the complexation of chitosan derivative with DNA. Chitosan derivatives ’
interaction with DDD with increasing charge ratios are shown in Apendix E. As the +/charge ratio is increased, the molar ellipticities of the DNA is suppressed; and the
positive band near 280 nm is shifted. TPAB-CS displays the most significant increase in
the signal of the negative band centered around 260 nm, and the most significant decrease
of the positive band at 280 nm . All chitosan derivatives displayed interactions with
DNA, as evidenced by the suppressed 260 nm (negative) signal and 280-290 nm
(positive) signal.69,70 Although changes in intensities were observed at 200-220 nm, their
interpretations are unclear, and were not used for investigating chitosan derivatives
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interaction with DNA.69,70 Although there are no conclusive conformational changes
from B to Z-form DNA, CD analysis did display an interaction between ammonium and
phosphonium chitosan derivatives with DDD.

Figure 28. CD analysis was conducted to examine complexation/interaction of
ammonium, and phosphonium, chitosan derivatives with DDD DNA using 1-42X
charge ratios. The non-PEGylated chitosan derivatives above represent complete
complexation at charge ratio 4X
3.8. Fluorescence Microscopy Studies
To evaluate if yeast cells would internalize ammonium or phosphonium
derivatives, fluorescence microscopy studies were conducted using a 3i Lambda XL GFP
488 lamp for excitation of FITC, an Orca R2 wide-lens microscope for visualization of
the cells, and Slidebook Image Capturing software for digitally capturing the images. The
procedure used for preparing the cells with FITC tagged chitosan derivatives is outlined
in section 2.1.9. In Figures 29 and 30, cells with FITC-tagged chitosan derivatives can be
seen as a green hue. An intensity heat map was used to visualize the yeast cells
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Figure 29. Fluorescence Microscopy results utilizing intensity heat mapping to
vizualize FITC tagged derivatives TMAB-CS, TEAB-CS, TPAB-CS, and TEPB-CS

Figure 30. Fluorescence Microscopy results utilizing intensity heat mapping to
vizualize FITC tagged derivatives TEAB-mPEG- g-CS, TEPB-mPEG-g-CS, and
TPPP-mPEG-g-CS
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containing FITC-tagged chitosan derivatives. A new preparation procedure and
visualization protocol for the internalization of FITC-tagged chitosan derivatives is being
implemented in future studies to improve the accuracy of the results. Further
investigations are underway to investigate the internalization of FITC-tagged chitosan
derivatives into mammalian cells. As for this study, the results can only conclude FITC
tagged derivatives are adsorbed to the cell membrane or internalized. Neither result can
be explicitly confirmed.

3.9. Yeast Growth Assays
The antifungal properties of ammonium and phosphonium chitosan derivatives
were examined using a BioTek ELx808 microplate reader and freshly inoculated yeast
cells. The preparation procedure for yeast growth assays is found in section 2.1.5. The
data collected was normalized by taking the final OD reading for each concentration,
dividing it by the final OD of the control, and multiplying by 100. The results of each
study were compiled into a plot and can be seen in Appendix G. The normalization of the
data was necessary for accurate comparisons to be made between each sample. Figure 31
displays a clear inhibition of yeast growth at just 5 μg/mL; while at 1 μg/mL, some
samples increased growth. TEPB-CS displayed the greatest inhibition of yeast growth
compared to TMAB-CS, TEAB-CS, and TPAB-CS. The promotion of yeast growth using
TMAB-CS and TPAB-CS is currently unexplained and is being researched further. For
all samples tested, no growth was observed at concentrations greater than 5 μg/mL.
Future experiments will narrow the concentration between 1 and 5 μg/mL to discover an
accurate inhibition cutoff.
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Figure 31. Yeast growth assay conducted using TMAB-CS, TEAB, TPAB-CS, and
TEPB-CS derivatives with concentrations of 0, 1, and 5 µg/mL to analize antifungal
properties
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CHAPTER 4. CONCLUSION
In this work, ammonium and phosphonium chitosan derivatives (see page 16,
Figure 4) have been synthesized and characterized by 1 H NMR, FT-IR, TGA, CD,
agarose gel electrophoreses, confocal microscopy, and yeast growth assays. Although
some ammonium derivatives have been reported in the literature, to the best of our
knowledge the synthesis and characterization of the derivatives made in this work have
not yet been reported in the literature.
TEPB-CS displayed the best interaction with Dickerson Drew Dodecamer DNA
when compared against all ammonium derivatives synthesized. 1 H NMR was able to
display the localization of positive charge found on phosphoniums derivatives; while FTIR was able to display strong coupling of the cationic carboxy ligands to chitosan.
Agarose gel electrophoreses observed that TEPB-CS was able to complex DDD at 1x
concentration, compared to that of ammonium where complete complexation occurred at
2x, or higher. CD was able to observe that TMAB-CS had the most significant interaction
with DDD when compared to the interactions of the chitosan derivatives. Finally, yeast
growth assays were conclusive in determining that TEPB-CS was able to inhibit yeast
growth better than ammonium compounds, and will be used in future studies with
mammalian cells to observe their interaction.
Future work will examine the cytotoxicity of the compounds made in this work as
well as the transfection efficiency with regard to mammalian cells.

60

REFERENCES
(1) Abbas, A. M. Iowa Research Online. 2010, 1-365.
(2) Henrissat, B. Chitin and Chitinases. 1999, 137–156.
(3) Kas, H. S. J. of Microencapsulation. 1997, 14, 689–711.
(4) Singla, A. K.; Chawla, M. J. of Pharmacy and Pharmacology. 2001, 53, 1047–1067.
(5) Argin-Soysal, S.; Kofinas, P.; Lo, Y. M. Food Hydrocolloids. 2009, 23, 202–209.
(6) Higashimura, T.; Sisido, M.; Fuyama, H. Polymer. 1977, 18, 291–294.
(7) Vårum, K. M.; Antohonsen, M. W.; Grasdalen, H.; Smidsrød, O. Carbohydrate
Research. 1991, 211, 17–23.
(8) Porter, C. Suicide Gene Therapy. 2009, 91–106.
(9) Fukazawa, K. International J. of Molecular Medicine. 2009, 25 (01).
(10) Chung, T. W.; Lu, Y. F.; Wang, H. Y.; Chen, W. P.; Wang, S. S.; Lin, Y. S.; Chu, S.
H. Artificial Organs. 2003, 27, 155–161.
(11) Kim, S. H.; Robbins, P. D. Lysosomal Storage Disorders. 2007, 53–67.
(12) Aiba, S. I. International J. of Biological Macromolecules. 1992, 14, 225–228.
(13) Lee, K. Y.; Ha, W. S.; Park, W. H. Biomaterials. 1995, 16, 1211–1216.
(14) Hirano, S. Biotechnology Annual Review. 1996, 237–258.
(15) Plance K. Material Science of Chitin and Chitosan. 2001, 165–190.
(16) Lamarque, G.; Lucas, J. M.; Viton, C.; Domard, A. Biomacromolecules. 2005, 6,
131–142.
(17) Ottey, M. Carbohydrate Polymers. 1996, 29, 17–24.
(18) Huang, M.; Khor, E.; Lim, L. Y. Pharmaceutical Research. 2004, 21, 344–353.
(19) Allan, G.; Peyron, M. Carbohydrate Research. 1995, 277, 257–272.
(20) Tokura, S.; Ueno, K.; Miyazaki, S.; Nishi, N. Macromolecular Symposia. 1997, 120,
1–9.
(21) Kiang, T.; Wen, J.; Lim, H. W.; Leong, K. W. Biomaterials. 2004, 25, 5293–5301.
(22) Köping-Höggård, M.; Melnikova, Y. S.; Vårum, K. M.; Lindman, B.; Artursson,
61

P. The J. of Gene Medicine. 2002, 5(2), 130–141.
(23) Margolis, H. Nature. 1998, 392, 857–857.
(24) Templeton, N.S.; Gene and Cell Therapy. 2015, 1271–1310.
(25) Scanlon, K.J.; Cancer Gene Therapy. 2004, 11, 841–841.
(26) Flotte, T. R.; J of Cellular Physiology. 2007, 213, 301–305.
(27) Boulaiz, H.; Cancer Gene Therapy by Viral and Non-viral Vectors. 2014, i-xii.
(28) Lavertu, M.; Méthot, S.; Tran-Khanh, N.; Buschmann, M. D. Biomaterials.
2006, 27, 4815–4824.
(29) Tan, W.; Zhang, J.; Luan, F.; Wei, L.; Chen, Y.; Dong, F.; Li, Q.; Guo,
Z. International J. of Biological Macromolecules. 2017, 102, 704–711.
(30) Qian, C.; Xu, X.; Shen, Y.; Li, Y.; Guo, S. Carbohydrate Polymers. 2013, 97, 676–
683.
(31) Kim, Y. H.; Gihm, S. H.; Park, C. R.; Lee, K. Y.; Kim, T. W.; Kwon, I. C.; Chung,
H.; Jeong, S. Y. Bioconjugate Chemistry. 2001, 12, 932–938.
(32) Kim, K.; Kwon, S.; Park, J. H.; Chung, H.; Jeong, S. Y.; Kwon, I. C.; Kim, I.S. Biomacromolecules. 2005, 6, 1154–1158.
(33) Dou, Xiaozheng; Missouri State University, 2015.
(34) Jiang, X.; Dai, H.; Leong, K. W.; Goh, S.-H.; Mao, H.-Q.; Yang, Y.-Y. The J. of
Gene Medicine. 2006, 8, 477–487.
(35) Dhulipala, V.; Maddali, K.; Welshons, W.; Reddy, C. Birth Defects Research Part
B: Developmental and Reproductive Toxicology. 2005, 74, 233–242.
(36) Weber, P. C.; Wendoloski, J. J.; Pantoliano, M. W.; Salemme, F. R. J. of the
American Chemical Society. 1992, 114, 3197–3200.
(37) Nakajima, N.; Ikada, Y. Bioconjugate Chem. 1995, 6, 123–130
(38) Tang, Y.; Cummins, J.; Huard, J.; Wang, B. Expert Opinion on Biological Therapy.
2010, 10, 395–408.
(39) Yeomans, D. C.; Wilson, S. P. Gene Therapy. 2009, 16, 502–508.
(40) Chalikonda, S.; Bartlett, D. L. Cancer Drug Discovery and Development Gene
Therapy for Cancer. 2004, 73–85.
(41) Lu, Y.; Madu, C. O. Expert Opinion on Drug Delivery. 2009, 7, 19–35.
62

(42) Schmidt-Wolf, G. D.; Schmidt-Wolf, I. G. Trends in Molecular Medicine. 2003, 9,
67–72.
(43) Gao, X.; Kim, K.-S.; Liu, D. The AAPS J. 2007, 9.
(44) Jaidee, A.; Rachtanapun, P.; Luangkamin, S. Advanced Materials Research.
2012, 506, 158–161.
(45) Köping-Höggård, M.; Vårum, K.; Issa, M.; Danielsen, S.; Christensen, B.; Stokke,
B.; Artursson, P. Gene Therapy. 2004, 11, 1441–1452.
(46) Boussif, O.; Lezoualch, F.; Zanta, M. A.; Mergny, M. D.; Scherman, D.; Demeneix,
B.; Behr, J. P. Proceedings of the National Academy of Sciences. 1995, 92, 7297–7301.
(47) Bragonzi, A.; Dina, G.; Villa, A.; Calori, G.; Biffi, A.; Bordignon, C.; Assael, B. M.;
Conese, M. Gene Therapy. 2000, 7, 1753–1760.
(48) Tang, M. X.; Redemann, C. T.; Szoka, F. C. Bioconjugate Chemistry. 1996, 7, 703–
714.
(49) Turunen, M. P.; Hiltunen, M. O.; Ruponen, M.; Virkamäki, L.; Jr, F. S.; Urtti, A.;
Ylä-Herttuala, S. Gene Therapy. 1999, 6, 6–11.
(50) Gebhart, C. L.; Kabanov, A. V. J of Controlled Release. 2001, 73, 401–416.
(51) Luo, D.; Saltzman, W. M. Nature Biotechnology. 2000, 18, 33–37.
(52) Godbey, W.; Wu, K. K.; Mikos, A. G. Biomaterials. 2001, 22, 471–480.
(53) Putnam, D.; Gentry, C. A.; Pack, D. W.; Langer, R. Proceedings of the National
Academy of Sciences. 2001, 98, 1200–1205.
(54) Regnström, K.; Ragnarsson, E. G. E.; Köping-Höggård, M.; Torstensson, E.;
Nyblom, H.; Artursson, P. Gene Therapy. 2003, 10, 1575–1583.
(55) Kunath, K. J of Controlled Release. 2003, 89, 113–125.
(56) Kulikov, S. N.; Lisovskaya, S. A.; Zelenikhin, P. V.; Bezrodnykh, E. A.; Shakirova,
D. R.; Blagodatskikh, I. V.; Tikhonov, V. E. European J of Medicinal Chemistry.
2014, 74, 169–178.
(57) Negishi, E.; Wang, G. 1,3-Dienes. 2009, 1.
(58) Maschmeyer, G. International J of Antimicrobial Agents. 2006, 27, 3–6.
(59) Cowen, L. E.; Anderson, J. B.; Kohn, L. M. Annual Review of Microbiology.
2002, 56, 139–165.
(60) Tan, W.; Li, Q.; Dong, F.; Chen, Q.; Guo, Z. Molecules. 2017, 22, 1438.
63

(61) Vorlfckova, M.; Sagi, J. Nucleic Acids Research. 1991, 19, 2343–2347.
(62) Nelson, H.; Finch, J.; Luisi, B.; Klug, A. 1992.
(63) Alexeev, D. G.; Lipanov, A. A.; Skuratovskii, I. Y. Nature. 1987, 325, 821–823.
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APPENDICES
Appendix A. NMR
The 1 H NMR Spectra was collected using a Varian 400 MHz NMR spectrometer
and plotted using Varian VNMRJ software. All the spectra presented in this appendix
displays a ppm range of -2-14 to display the isolation of each compound free of starting
materials or impurities. The red lines indicate the range of which integration occurred and
their values presented in red under the spectra. Thee ppm values of all signals are
indicated in blue are located above the spectra.

Appendix A-1. 1 H NMR spectrum of (1-Carboxymethyl) trimethylammonium chloride. 4.33
(2H, -CH2 N+(CH3 )3 ), 3.19 (9H, -N+(CH3 )3 ), DMSOd6
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Appendix A-2. 1 H NMR spectrum of (1-Carboxymethyl) triethylammonium chloride.
DMSOd6 : 4.18 (2H, -CH2 N+(CH2 CH3 )3 ), 3.44 (6H, -N+(CH2 CH3 )3 ), 1.16 (9H, N+(CH2 CH3 )3 .

Appendix A-3. 1 H NMR spectrum of (1-Carboxymethyl) tripropylammonium chloride.
DMSOd6 : 3.29 (2H, HO2 CCH2 -), 2.96 (6H, -N+(CH2 CH2 CH3)3 ), 1.62 (6H, N+(CH2 CH2 CH3 )3), 0.85 (9H, -N+(CH2 CH2 CH3 )3
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Appendix A-4. 1 H NMR spectrum of (1-Carboxymethyl) triethylphosphonium chloride. 3.75
(2H, -H2 P +(CH2 CH3)3 ), 2.30 (6H, HO2 CCH2 P +(CH2 CH3)3 ), 1.10 (9H, -P +(CH2 CH3)3

Appendix A-5. 1 H NMR spectrum of (3-Carboxypropyl) trimethylammonium chloride.
12.31 (1H, HO2 CCH2 -), 3.01 (9H, -CH2 CH2 CH2 N(CH3)3 ), 2.71 (2H, CH2 CH2 CH2 N+(CH3 )3), 2.26 (2H, -CH2 CH2 CH2 N+(CH3 )3 ), 1.88 (2H, CH2 CH2 CH2 N+(CH3 )3
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Appendix A-6. 1 H NMR spectrum of (3-Carboxypropyl) triethylammonium chloride. 12.31
(1H, HO2 CCH2 -), 3.20 (9H, -N+(CH2 CH3 )3 ), 3.07 (2H, -CH2 N+(CH2 CH3 )3), 2.31 (2H, CH2 CH2 CH2 N+-), 1.75 (2H, -CH2 CH2 CH2 N+-), 1.13 (2H, -N+(CH2 CH2 )3

Appendix A-7. 1 H NMR spectrum of (3-Carboxypropyl) tripropylammonium chloride. 12.31
(1H, HO2 CCH2 -), 3.20 (9H, -N+(CH2 CH2 CH3 )3), 3.07 (2H, -CH2 N+(CH2 CH2 CH3 )3), 2.31 (2H,
-CH2 CH2 CH2 N+-), 1.75 (2H, -CH2 CH2 CH2 N+- ), 1.13 (2H, -N+(CH2 CH2 CH3 )
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Appendix A-8. 1 H NMR spectrum of (2-Carboxyethyl) triethylphosphonium chloride. 12.58
(1H, HO2 CCH2 -), 2.55 (2H, -CH2 CH2 P +-), 2.39 (2H, -CH2 P +(CH2 CH3 )3), 2.23 (6H, P +(CH2 CH3 )3 ), 1.08 (9H, -P +(CH2 CH3 )3

Appendix A-9. 1 H NMR spectrum of (3-Carboxypropyl) triethylphosphonium chloride.
12.16 (1H, HO2 CCH2 CH2-), 2.36 (2H, HO2 CCH2 CH2 CH2 -), 2.26 (2H, -CH2 P +(CH2 CH3 )3),
2.22 (6H, -P +(CH2 CH3 )3), 1.67 (2H, -CH2 CH2 P +(CH2 CH3 )3 ), 1.08 (9H, -P +(CH2 CH3 )3
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Appendix A-10. 1 H NMR spectrum of 95% Chitosan. 4.45 (1H, anomeric H), 3.80-3.30 (6H,
C2 -C6 H’s).

Appendix A-11. 1 H NMR spectrum of 2-(N-4-trimethylammonium chloride) butanamide
chitosan. 4.45 (1H, anomeric H), 3.80-3.30 (6H, C2 -C6 H’s), 3.21 (2H, -CH2 CH2 N+(CH3)),
2.98 (9H, -CH2 CH2 N+(CH3 )), 2.29 (2H, -OCH2 CH2 CH2N+(CH3 )), 1.96 (2H, CH2 CH2 N+(CH3 ).
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Appendix A-12. 1 H NMR spectrum of 2-(N-4-triethylammonium chloride) butanamide
chitosan. 4.43 (1H, anomeric H), 4.0-3.25 (6H, C2 -C6 H’s), 3.15 (2H, -N+(CH2 CH3)3 ), 3.04
(9H, -CH2 CH2 N+(CH2 CH3)3 ), 2.66 (1-2H, -2H-NHCOCH2 -), 2.28 (2H, -OCH2 CH2 CH2 N+-,
1.84 (2H, -CH2 CH2 N+( CH2 CH3)3, 1.11 (2H, -CH2 CH2 N+( CH2 CH3)3

Appendix A-13. 1 H NMR spectrum of 2-(N-4-tripropylammonium chloride) butanamide
chitosan. 4.48 (1H, C1 -Anomaric H), 4.0-3.25 (6H, C2 -C6 H’s), 3.04 (6H, -N+(CH2 CH2 CH3)3 ),
2.74 (2H, -CH2 N+(CH2 CH2 CH3)3 ) , 2.26 (2H, -CH2 CH2 CH2 N+-), 1.85 (2H, -CH2 CH2 N+-),
1.55 (6H, -N+(CH2 CH2 CH3 )3 ), 0.79 (9H, -N+(CH2 CH2 CH3 )3
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Appendix A-14. 1 H NMR spectrum of 2-(N-3-triethylphosphonium chloride)
propionamide chitosan. 4.48 (1H, anomeric H), 4.0-2.66 (6H, C2 -C6 H’s,2H-NH), 2.55
(2H, -CH2 CH2 N+(CH2 CH3 )3), 2.38 (2H, -CH2 N+(CH2 CH3 )3) , 2.11 (6H, CH2 N+(CH2 CH3 )3), 1.09 (9H, -CH2 N+(CH2 CH3 )3

Appendix A-15. 1 H NMR spectrum of 2-(N-4-triethylphosphonium chloride) butanamide
chitosan. 4.82 (1H, anomeric H), 4.0-2.66 (6H, C2 -C6 H’s ,2H-NH), 2.35 (2H, OCH2 CH2 CH2 N+ -), 2.07 (6H, -N+(CH2 CH3 )3 ) , 2.07 (2H, -CH2 N+(CH2 CH3 )3), 1.75 (2H, CH2 CH2 N+(CH2 CH3 )3), 1.08 (9H, - N+(CH2 CH3 )3
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Appendix A-16. 1 H NMR spectrum of 2-(N-5-triphenylphosphonium chloride)
pentanamide chitosan. 7.65-7.50 (15H, P+Ph3 -CH2 CH2 -), 4.39 (1H, anomeric H),
4.0-2.66 (6H, C2 -C6 H’s ,2H-NH), 3.13 (2H, P +Ph3 -CH2 CH2-), 2.16 (2H, P +Ph3 CH2 CH2 CH2 CH2 -), 1.60 (4H, P +Ph3 -CH2 CH2 CH2 -)
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Appendix B. IR
The IR Spectra was collected using a Bruker Vertex 70 FT-IR spectrometer and
plotted using Bruker OPUS 7.5 software. All the spectra presented in this appendix
displays a wavenumber (cm-1 ) range of 400-4000 to display the amide I, amide II, C-O,
N-H, C-H, C-N+, and C-P+ stretch peaks found on coupled chitosan derivatives. The
wavenumber (cm-1 ) values of all signals are indicated in black are located below the
spectra.

Appendix B-1. IR spectrum of 95% DA Chitosan
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Appendix B-2. IR spectrum of 2-(N-4-trimethylammonium chloride)
butanamide chitosan.

Appendix B-3. IR spectrum of 2-(N-4-triethylammonium chloride)
butanamide chitosan.
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Appendix B-4. IR spectrum of 2-(N-4-tripropylammonium chloride) butanamide
chitosan.

Appendix B-5. IR spectrum of 2-(N-3-triethylphosphonium chloride) propionamide
chitosan
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Appendix B-6. IR spectrum of 2-(N-4-triethylphosphonium chloride) butanamide
chitosan

Appendix B-7. IR spectrum of 2-(N-5-triphenylphosphonium chloride)
pentanamide chitosan
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Appendix B-8. IR spectrum of 2-(N-4-triethylphosphonium chloride) butanamide
mPEG-g-chitosan

Appendix B-9. IR spectrum of 2-(N-4-triethylphosphonium chloride) butanamide
chitosan
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Appendix B-10. IR spectrum of 2-(N-5-triphenylphosphonium chloride) pentanamide
chitosan
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Appendix C. TGA and DTG
TGA (green) and DTG (blue) was conducted to examine the change in stability of
chitosan’s polymer chain after coupling of carboxy ligands. The TGA and DTG Spectra
were collected using a TA Instrument Q600 Thermogravimetric Analyzer and plotted
using TA Universal Analyzer software. All the spectra presented in this appendix
displays weight % (green), and 1st Derivative weight % (blue) of all chitosan derivatives.
The beginning and end of each degradation phase are marked along the TGA (green)
spectra.

Appendix C-1. TGA and DTG analysis of 95% DA Chitosan
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Appendix C-2. TGA-DTG 2-(N-4-trimethylammonium chloride)
butanamide chitosan

Appendix C-3. TGA-DTG analysis of 2-(N-4-triethylammonium
chloride) butanamide chitosan
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Appendix C-4. TGA-DTG analysis of 2-(N-4-tripropylammonium
chloride) butanamide chitosan

Appendix C-5. TGA-DTG analysis of 2-(N-3-triethylphosphonium
chloride) propionamide chitosan
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Appendix C-6. TGA-DTG analysis of 2-(N-4-triethylphosphonium
chloride) butanamide chitosan

Appendix C-7. TGA-DTG analysis of 2-(N-5-triphenylphosphonium
chloride) pentanamide chitosan
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Appendix D. Agarose Gel Electrophoresis
Agarose gel electrophoresis was conducted to examine complexation affinity of
all cationic chitosan derivatives. The images were visualized using ethidium bromide,
short-wave UV light, and Microsoft Windows image capturing software. All chitosan
derivatives examined with Drew Dickerson Dodecamer DNA are shown in this appendix
using 2% agarose gel. Wells are in charge ratios of 1) 16x, 2) 8x, 3) 4x, 4) 2x, 5) 1x, 6)
0.5x, 7) 0.25x, 8) Control

+

1 2 3 4 5 6 7 8
Appendix D-1. Agarose gel electrophoresis result of TMAB-CS. Wells are in charge
ratios of 1) 16, 2) 8, 3) 4, 4) 2, 5) 1, 6) 0.5, 7) 0.25, 8) Control
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+

1 2 3 4 5 6 7 8
Appendix D-2. Agarose gel electrophoresis result of TEAB-CS. Wells are in charge
ratios of 1) 16, 2) 8, 3) 4, 4) 2, 5) 1, 6) 0.5, 7) 0.25, 8) Control

+

1 2 3 4 5 6 7 8
Appendix D-3. Agarose gel electrophoresis result of TPAB-CS. Wells are in charge
ratios of 1) 16, 2) 8, 3) 4, 4) 2, 5) 1, 6) 0.5, 7) 0.25, 8) Control
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+

1 2 3 4 5 6 7 8
Appendix D-4 Agarose Gel of Agarose gel electrophoresis result of TEPPr-CS. Wells
are in charge ratios of 1) 16, 2) 8, 3) 4, 4) 2, 5) 1, 6) 0.5, 7) 0.25, 8) Control

+
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Appendix D-5. Agarose Gel of Agarose gel electrophoresis result of TEPB-CS. Wells
are in charge ratios of 1) 16, 2) 8, 3) 4, 4) 2, 5) 1, 6) 0.5, 7) 0.25, 8) Control
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Appendix D-6. Agarose Gel of Agarose gel electrophoresis result of TPPP-CS. Wells
are in charge ratios of 1) 16, 2) 8, 3) 4, 4) 2, 5) 1, 6) 0.5, 7) 0.25, 8) Control

+

1 2 3

4 5 6 7 8

Appendix D-7. Agarose Gel of Agarose gel electrophoresis result of TEAB-mPEGCS. Wells are in charge ratios of 1) 16, 2) 8, 3) 4, 4) 2, 5) 1, 6) 0.5, 7) 0.25, 8) Control
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+

+

1 2 3

4 5 6 7 8

- Gel of Agarose gel electrophoresis
Appendix D-8. Agarose

result of TEPB-mPEG-CS.
4 4,54) 2,
6 5)71, 86) 0.5, 7) 0.25, 8) Control
Wells are in charge ratios of 1)1 16,2 2)38, 3)

+

1 2 3

4 5 6 7 8

Appendix D-9. Agarose Gel of Agarose gel electrophoresis result of TEPB-mPEGCS. Wells are in charge ratios of 1) 16, 2) 8, 3) 4, 4) 2, 5) 1, 6) 0.5, 7) 0.25, 8) Control
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Appendix E. Circular Dichroism (CD)
Circular Dichroism was conducted to examine changes in conformational states
and complexation affinity of all cationic chitosan derivatives using DDD DNA. CD
spectra were obtained using Jasco J-815 spectrometer coupled with PFD-425s Single
Position Peltier. All spectra in this appendix were gathered using cationic chitosan
derivatives with B-form DNA and evaluated between 210-300 nm.

Appendix E-1. CD spectrum of 2-(N-4-trimethylammonium chloride) butanamide
chitosan was examine using charge ratios of 1x, 2x, 4x, 8x, 16x, 32x, 42x.
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Appendix E-2. CD spectrum of 2-(N-4-triethylammonium chloride) butanamide
chitosan was examine using charge ratios of 1x, 2x, 4x, 8x, 16x, 32x, 42x.

Appendix E-3. CD spectrum of 2-(N-4-propylammonium chloride) butanamide
chitosan was examine using charge ratios of 1x, 2x, 4x, 8x, 16x, 32x, 42x.
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Appendix E-4. CD spectrum of 2-(N-3-triethylphosphonium chloride) propionamide
chitosan was examine using charge ratios of 1x, 2x, 4x, 8x, 16x, 32x, 42x.

Appendix E-5. CD spectrum of 2-(N-4-triethylphosphonium chloride) butanamide
chitosan was examine using charge ratios of 1x, 2x, 4x, 8x, 16x, 32x, 42x.
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Appendix E-6. CD spectrum 2-(N-4-triethylammonium chloride) butanamide mPEGg-chitosan was examine using charge ratios of 1x, 2x, 4x, 8x, 16x, 32x, 42x.

Appendix E-7. CD spectrum 2-(N-4-triethylphosphonium chloride) butanamide
mPEG-g-chitosan was examine using charge ratios of 1x, 2x, 4x, 8x, 16x, 32x, 42x.
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Appendix F. Fluorescence Microscopy
To evaluate chitosan derivatives ability to be internalized by yeast they were
examined using fluorescence microscopy studies. Chitosan derivatives were tagged with
FITC, incubated with yeast cells, then washed and placed on a slide and examined. All
chitosan derivative images obtained were digitally colored using intensity heat mapping
and are displayed in this appendix.

Appendix F-1. Fluorescence microscopy image of FITC tagged 2-(N-4trimethylammonium chloride) butanamide chitosan with yeast cells
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Appendix F-2. Fluorescence microscopy image of FITC tagged 2-(N-4triethylammonium chloride) butanamide chitosan with yeast cells

Appendix F-3. Fluorescence microscopy image of FITC tagged 2-(N-4tripropylammonium chloride) butanamide chitosan with yeast cells
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Appendix F-4. Fluorescence microscopy image of FITC tagged 2-(N-4triethylphosphonium chloride) butanamide chitosan with yeast cells

Appendix F-5. Fluorescence microscopy image of FITC 2-(N-4-triethylammonium
chloride) butanamide mPEG-g-chitosan with yeast cells
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Appendix F-6. Fluorescence microscopy image of FITC 2-(N-4-triethylphosphonium
chloride) butanamide mPEG-g-chitosan with yeast cells.

Appendix F-7. Fluorescence microscopy image of 2-(N-5-triphenylphosphonium
chloride) pentanamide mPEG-g-chitosan with yeast cells
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Appendix G. Yeast Growth Assays
Chitosan derivatives antifungal properties were evaluated using freshly inoculated
yeast cells to test for potential growth inhibition. All cells were placed into a 96 well
plate with various concentration of chitosan derivatives ranging from 0.1-1000 µg/mL
and examined over 24 hours with their OD read every 10 minutes. The spectra shown in
this appendix has concentrations of 0, 0.1, and 5 µg/mL, all other concertation’s
completely inhibited growth.

Appendix G-1. 2-(N-4-trimethylammonium chloride) butanamide chitosan’s Yeast
Growth Assay over the period of 24 hours
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Appendix G-2. 2-(N-4-triethylammonium chloride) butanamide chitosan’s Yeast
Growth Assay over the period of 24 hours

Appendix G-3. 2-(N-4-tripropylammonium chloride) butanamide chitosan’s Yeast
Growth Assay over the period of 24 hours
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Appendix G-4. 2-(N-4-triethylphosphonium chloride) butanamide chitosan’s Yeast
Growth Assay over the period of 24 hours
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